Glycine regulatory elements and their uses

By providing efficient regulatory elements from species of soybean, the problem of limited selection of promoter and terminator sequences in the prior art is solved, efficient gene expression in various tissues in soybeans is achieved, and resistance and tolerance of plants are enhanced Receptive properties.

CN114746555BActive Publication Date: 2024-11-01SYNGENTA CROP PROTECITON AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080081876.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-11-25
Filing Date
2020-11-23
Publication Date
2024-11-01
Estimated Expiration
2040-11-23

AI Technical Summary

Technical Problem

In the prior art, the selection of promoter and terminator sequences in expression cassettes used in plants such as soybeans is limited, making it difficult to achieve robust protein production, especially in most soybean tissues.

Method used

Providing regulatory elements such as promoter and terminator sequences from Soybean species are shown to have improved expression levels in leaves, roots, seed pods and embryos by comparison with control sequences and are used to construct expression cassettes to drive genes Express.

Benefits of technology

It has achieved efficient driving gene expression in a variety of soybean tissues, providing more selectivity for the construction of transgenic plants, and enhancing the expression of plant resistance and tolerance characteristics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114746555B_ABST
    Figure CN114746555B_ABST
Patent Text Reader

Abstract

This article provides regulatory elements derived from or obtained from various soybean species, such as promoters and terminators. Such regulatory elements can be used for expression cassettes of plants such as soybeans. Such expression cassettes usually contain promoter and terminator sequences to control the expression of each encoding sequence. For certain traits, such as insect resistance and herbicide tolerance, it may be necessary to use promoters and terminators with medium to high constitutive expression.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Related Applications

[0002] This application claims priority to provisional application 62 / 939,762, filed on November 25, 2019, and is incorporated herein by reference in its entirety. Technical Field

[0003] The present invention relates to regulatory elements, such as promoters and terminators, which can be used in expression cassettes in plants such as soybean.

[0004] Sequence Listing

[0005] This application is accompanied by a sequence listing named 82000_ST25.txt created on November 16, 2020, which is approximately 54kb in size. This sequence listing is incorporated herein by reference in its entirety. This sequence listing is submitted with this application via EFS-Web and complies with 37 C.FR §1.824(a)(2)-(6) and (b). Background Art

[0006] Transgenic plants are an important source of desirable traits, such as insect resistance and herbicide tolerance. To produce such traits, one or more nucleic acids are typically introduced into plants containing expression cassettes that express one or more coding sequences for one or more traits. Such expression cassettes typically contain promoter and terminator sequences to control the expression of each coding sequence. For certain traits, such as insect resistance and herbicide tolerance, it may be necessary to use promoters and terminators with medium to high constitutive expression. The selection of such promoters and terminators is still limited. Additional promoter and terminator sequences are still needed to drive gene expression to achieve robust protein production, ideally in all or most soybean tissues. Summary of the invention

[0007] Provided herein are regulatory elements, such as promoters and terminators, obtained or derived from Glycine species, such as Glycine argyrea, Glycine canescens, Glycine clandestine, Glycine max, and Glycine tomentella. Such regulatory elements can be used to construct expression cassettes for expressing a coding sequence of interest, such as an expression cassette for a coding sequence of a trait of interest in a plant. As described herein, several promoter and terminator sequences were tested and shown to have increased expression levels in leaves, roots, seed pods, and / or embryos compared to control promoters or terminators. Therefore, some aspects of the present disclosure relate to such regulatory elements and their use in expression cassettes, vectors, and transgenic plants and plant cells.

[0008] In some embodiments, the disclosure provides an expression cassette comprising a nucleotide sequence having at least 90% identity (e.g., at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identity) to one or more of SEQ ID NOs: 1-5, 8-29, or 31, wherein the nucleotide sequence is operably linked to a heterologous nucleotide sequence. In some embodiments, the disclosure provides an expression cassette comprising a nucleotide sequence comprising one or more of SEQ ID NOs: 1-5, 8-29, or 31, or a biologically active fragment thereof, wherein the nucleotide sequence is operably linked to a heterologous nucleotide sequence. In some embodiments, the disclosure provides an expression cassette comprising a first nucleotide sequence that is at least 90% identical (e.g., at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical) to one or more of SEQ ID NOs: 1-5 and a second nucleotide sequence that is at least 90% identical (e.g., at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% identical) to one or more of SEQ ID NOs: 8-29, wherein the first and / or second nucleotide sequence is operably linked to a heterologous nucleotide sequence.

[0009] In some embodiments, the heterologous nucleotide sequence is a target nucleic acid encoding a target RNA or protein. In some embodiments, the target RNA or protein can confer desirable characteristics on plants, such as antibiotic resistance, virus resistance, insect resistance, disease resistance, resistance to other harmful organisms, herbicide tolerance, improved nutritional value, improved performance in industrial processes, or altered reproductive capacity. In some embodiments, the heterologous nucleotide sequence encodes a selective marker. In some embodiments, the expression cassette further comprises a selective marker.

[0010] In some embodiments, the disclosure provides a vector comprising an expression cassette as described in any one of the above embodiments. In some embodiments, the vector is a plasmid, a virus, or Agrobacterium.

[0011] In some embodiments, the disclosure provides a plant cell comprising an expression cassette or vector as described in any one of the above embodiments. In some embodiments, the plant cell is a dicotyledonous plant cell. In some embodiments, the plant cell is a soybean cell. In some embodiments, the disclosure provides a transgenic plant comprising the plant cell. In some embodiments, the plant is a dicotyledonous plant. In some embodiments, the plant is a soybean plant. In some embodiments, the disclosure provides seeds from a transgenic plant.

[0012] In some embodiments, the disclosure provides a method comprising introducing an expression cassette or vector as described in any one of the above embodiments into a plant or plant cell. In some embodiments, the method further comprises placing the plant or plant cell under conditions where the expression cassette or vector expresses the target RNA or protein and / or a selective marker. In some embodiments, the method further comprises crossing the plant with a second plant or selfing the plant to produce a progeny plant.

[0013] In some embodiments, the disclosure provides a transgenic plant produced by the method of any one of the above embodiments, or a plant part thereof. In some embodiments, the plant is a dicotyledonous plant. In some embodiments, the plant is a soybean plant. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] Figure 1 is a graph showing Bx9 expression in T1 soybean seedling leaves. Hom = homozygous, Het = heterozygous. 24244 = prGaUbi599400; 24245 = prGcUbiPI339656; 24246 = prGtUbiPI505267; 24247 = prGaEF1aPI599400; 24249 = prGaSAMSPI599400, negative control; 24276 = prGmSAMS, positive control. Markers A010A, A021A, A027A, etc. represent different events.

[0015] Figure 2 is a graph showing Bx9 expression in mature leaves of T1 soybean at the reproductive stage. Hom = homozygous, Het = heterozygous. 24244 = prGaUbi599400; 24245 = prGcUbiPI339656; 24246 = prGtUbiPI505267; 24247 = prGaEF1aPI599400; 24249 = prGaSAMSPI599400, negative control; 24276 = prGmSAMS, positive control. Markers A027A, A021A, A023A, etc. represent different events, respectively.

[0016] Figure 3is a graph showing Bx9 expression in T1 soybean roots at the reproductive stage. Hom = homozygous, Het = heterozygous. 24244 = prGaUbi599400; 24245 = prGcUbiPI339656; 24246 = prGtUbiPI505267; 24247 = prGaEF1aPI599400; 24249 = prGaSAMSPI599400, negative control; 24276 = prGmSAMS, positive control. Markers A027A, A021A, A023A, etc. represent different events, respectively.

[0017] Figure 4 is a graph showing Bx9 expression in T1 soybean seed pods. Hom = homozygous, Het = heterozygous. 24244 = prGaUbi599400; 24245 = prGcUbiPI339656; 24246 = prGtUbiPI505267; 24247 = prGaEF1aPI599400; 24249 = prGaSAMSPI599400, negative control; 24276 = prGmSAMS, positive control. Markers A027A, A021A, A023A, etc. represent different events.

[0018] Figure 5 is a graph showing Bx9 expression in T1 soybean homozygous embryos. 24244 = prGaUbi599400; 24245 = prGcUbiPI339656; 24246 = prGtUbiPI505267; 24247 = prGaEF1aPI599400; 24249 = prGaSAMSPI599400, negative control; 24276 = prGmSAMS, positive control. Markers A027A, A021A, A023A, etc. represent different events.

[0019] Figure 6 is a graph showing Bx9 expression in T1 soybean seedling leaves. Hom = homozygous, Het = heterozygous. Markers A010A, A005A, A016A, etc. represent different events.

[0020] Figure 7 It is a graph showing the expression of Bx9 in homozygous mature leaves of T1 soybean at the reproductive stage. The markers A010A, A005A, A016A, etc. represent different events, respectively.

[0021] Figure 8 is a graph showing Bx9 expression in homozygous roots of T1 soybean at the reproductive stage. The markers A010A, A005A, A016A, etc. represent different events, respectively.

[0022] Fig. 9The graph shows the expression of Bx9 in homozygous seed pods of T1 soybean. The markers A010A, A005A, A016A, etc. represent different events.

[0023] Fig.10 The diagram shows the expression of Bx9 in homozygous T1 soybean embryos. The markers A010A, A005A, A016A, etc. represent different events.

[0024] Brief description of the sequences in the sequence listing

[0025] SEQ ID NO: 1 is the promoter prGaUbiPI599400.

[0026] SEQ ID NO: 2 is the promoter prGcUbiPI339656.

[0027] SEQ ID NO: 3 is the promoter prGtUbiPI505267.

[0028] SEQ ID NO: 4 is the promoter prGaEF1aPI599400.

[0029] SEQ ID NO: 5 is the promoter prGmEF1aGlyma17G186600.

[0030] SEQ ID NO: 6 is the promoter prGaSAMS599400.

[0031] SEQ ID NO: 7 is the promoter prGmSAMS.

[0032] SEQ ID NO: 8 is the terminator tGmEF1a17G18600.

[0033] SEQ ID NO:9 is the terminator tGtUbiPI505267.

[0034] SEQ ID NO: 10 is the terminator tGaEF1aPI599400.

[0035] SEQ ID NO: 11 is the terminator tGmMIP02G255000.

[0036] SEQ ID NO: 12 is the terminator tGtMIPPI505267.

[0037] SEQ ID NO: 13 is the terminator tGIMIPPI546970.

[0038] SEQ ID NO: 14 is the terminator tGcUbiPI339656.

[0039] SEQ ID NO: 15 is the terminator tGtEF1aPI441001.

[0040] SEQ ID NO: 16 is the terminator tGaUbiPI599400.

[0041] SEQ ID NO: 17 is the terminator tGcUbiPI595799.

[0042] SEQ ID NO: 18 is the terminator tGcSAMSPI339656.

[0043] SEQ ID NO: 19 is the terminator tGmRBPGlyma11G117300.

[0044] SEQ ID NO: 20 is the terminator tGmMIPGlyma19G186100.

[0045] SEQ ID NO:21 is the terminator tGaSAMSPI599400.

[0046] SEQ ID NO:22 is the terminator tGaMIPPI505151.

[0047] SEQ ID NO:23 is terminator tGtEF-02PI441001.

[0048] SEQ ID NO: 24 is terminator tGaEF-02PI599400.

[0049] SEQ ID NO: 25 is terminator tGaADF3PI599400.

[0050] SEQ ID NO:26 is the terminator tGcEF-02PI483193.

[0051] SEQ ID NO: 27 is the terminator tGmPOXGlyma07G260300.

[0052] SEQ ID NO:28 is the terminator tGtSAMsPI505267.

[0053] SEQ ID NO:29 is terminator tGaRBPPI599400.

[0054] SEQ ID NO:30 is terminator tMt51186.

[0055] SEQ ID NO:31 is the promoter prGaUbiPI599400-02.

[0056] definition

[0057] Although it is believed that the following terms are well understood by one of ordinary skill in the art, the following definitions are set forth to facilitate understanding of the disclosed subject matter.

[0058] Unless otherwise defined below, all technical and scientific terms used herein are intended to have the same meaning as commonly understood by those of ordinary skill in the art. References to the technology employed herein are intended to reference technology commonly understood in the art, including variations of those technologies that are clear to those skilled in the art or replacement of equivalent technologies.

[0059] All patents, patent publications, and non-patent publications cited herein are incorporated by reference in their entirety for the teachings of the relevant sentence or paragraph mentioned in the citation. In the event of a conflict in terminology, the present specification controls.

[0060] As used herein, the term "a" or "an" or "the" may refer to one or more than one, unless the context clearly and explicitly indicates otherwise. For example, "an" endogenous nucleic acid may refer to one endogenous nucleic acid or multiple endogenous nucleic acids.

[0061] The term "about" is used herein to mean approximately, roughly, about, or around. When the term "about" is used in conjunction with a numerical range, it defines the range by extending the boundaries above and below the stated values. Typically, the term "about" is used herein to define a numerical value to a variation of 20%, preferably 10% above and below (higher or lower) above and below the specified value. With respect to temperature, the term "about" means ±1°C, preferably ±0.5°C. When the term "about" is used in the context of the present invention (e.g., in combination with a temperature or molecular weight value), an exact value (i.e., no "about") is preferred.

[0062] The phrase "and / or" used in this specification and claims should be understood to mean "either or both" of the elements so combined, i.e., elements that appear in combination in some cases or separately in other cases. Multiple elements listed with "and / or", i.e., "one or more elements" of the elements so combined, should be interpreted in the same manner. Other elements different from the elements specifically identified by the "and / or" clause may optionally be proposed, whether associated or not associated with those elements specifically identified. Thus, as a non-limiting example, when used in conjunction with open language such as "comprising", a reference to "A and / or B" can refer to only A (optionally including elements different from B) in one embodiment; and in another embodiment, can refer to only B (optionally including elements different from A); and in yet another embodiment, refer to both A and B (optionally including other elements); etc. "Or" used in this specification and claims should be understood to have the same meaning as "and / or" as defined above.

[0063] As used herein, "biologically active fragment" refers to a fragment of a reference sequence that has an activity that is substantially equal (e.g., at least 90% equal) or greater than the activity of the reference sequence. For example, a biologically active fragment of a reference promoter would be a fragment that can drive expression of a coding sequence at a level that is substantially equal to or greater than that of the reference promoter.

[0064] A "coding sequence" is a nucleic acid sequence that is transcribed into RNA (e.g., mRNA, rRNA, tRNA, snRNA, sense RNA, or antisense RNA). In some embodiments, the RNA is subsequently translated in vivo to produce a protein.

[0065] As used herein, the term "elite" and / or "elite line" refers to any line that is essentially homozygous and is the result of breeding and selection for desirable agronomic performance.

[0066] An "enhancer" is a nucleotide sequence that can stimulate the activity of a promoter and can be an intrinsic element of the promoter or an inserted heterologous element to enhance the level or tissue specificity of the promoter. The primary sequence can be present on either strand of a double-stranded DNA molecule and can function even when placed upstream or downstream of the promoter.

[0067] When used with reference to polynucleotides (such as genes, ORFs or parts thereof, or transgenics of plants), the term "expression" refers to the process of converting the genetic information encoded in a gene into RNA (e.g., mRNA, rRNA, tRNA or snRNA) by the "transcription" of a gene (i.e., via the enzymatic action of an RNA polymerase), and into a protein by the "translation" of mRNA in applicable cases (e.g., if the gene encodes a protein). Gene expression can be regulated at many stages of the process. For example, in the case of an antisense construct or a dsRNA construct, expression may refer to only the antisense RNA or only the transcription of the dsRNA, respectively. In an embodiment, "expression" refers to the transcription and stable accumulation of a sense (mRNA) or functional RNA. "Expression" may also refer to the production of a protein.

[0068] As used herein, "expression cassette" means a nucleic acid molecule that can direct a specific polynucleotide or polynucleotides to be expressed in a suitable host cell, comprising a promoter operably connected to one or more target polynucleotides (which are operably connected to a termination signal). The expression cassette also typically comprises polynucleotides that require appropriate translation of one or more target polynucleotides. The expression cassette may also be included in polynucleotides that are not necessary for the direct expression of the target polynucleotides but exist due to convenient restriction sites for removing the expression cassette from the expression vector. The expression cassette comprising one or more target polynucleotides may be chimeric, meaning that at least one of its components is heterologous relative to at least one of its other components. The expression cassette may also be a naturally occurring expression cassette that has been obtained in a recombinant form useful for heterologous expression. However, typically the expression cassette is heterologous relative to the host, i.e., the specific polynucleotides of the expression cassette are not naturally occurring in the host cell, and must have been introduced into the host cell or the ancestor of the host cell by transformation methods known in the art. The expression of one or more polynucleotides in the expression cassette is usually under the control of a promoter. In the case of multicellular organisms (such as plants), the promoter may also be specific or preferential for a particular tissue, or organ, or developmental stage. When transformed into a plant, the expression cassette or fragment thereof may also be referred to as an "inserted polynucleotide" or "inserted polynucleotide."

[0069] As used herein, the term "genome editing agent" refers to an agent that can induce deletions, insertions, indels, or other modifications in a cell's genome, for example, by generating single-strand or double-strand breaks in the genome. Examples of genome editing agents include CRISPR / Cas reagents (e.g., Cas proteins and guide RNAs), transcription activator-like effector nucleases (TALENs), DNA-guided nucleases, meganucleases, recombinases, and zinc finger nucleases. Cas proteins include Cas9, Cpf1 (also known as Cas12a), C2c1, C2c2, and C2c3, and their functional variants. Example Cas9 and Cpf1 proteins include Streptococcus pyogenes Cas9 (SpCas9), Streptococcus thermophilus Cas9 (StCas9), Streptococcus pasteurianus (SpaCas9), Campylobacter jejuni Cas9 (CjCas9), Staphylococcus aureus (SaCas9), Francisella novicida Cas9 (FnCas9), Neisseria cinerea Cas9 (NcCas9), Neisseria meningitis Cas9 (NmCas9), Francisella novicida Cpf1 (FnCpf1), Acidaminococcus sp. Cpf1 (AsCpf1), or Lachnospiraceae bacteria. bacterium) ND2006 Cpf1 (LbCpfl). A "variant" of a Cas protein refers to a protein or polypeptide derivative of a wild-type Cas protein, such as a protein having one or more point mutations, insertions, deletions, truncations, fusion proteins, or a combination thereof. In certain embodiments, the Cas variant is a functional variant that substantially retains the nuclease activity of the wild-type Cas protein or has better nuclease activity than the wild-type Cas protein. Examples of guide RNAs include single guide RNAs and dual guide RNAs.

[0070] A "heterologous" nucleic acid sequence is a nucleic acid sequence that is not naturally associated with a host cell into which the nucleic acid sequence is introduced, including non-naturally occurring multiple copies of a naturally occurring nucleic acid sequence. A nucleic acid sequence can also be heterologous to other nucleic acid sequences associated therewith, such as in a nucleic acid construct, such as, for example, an expression vector. As a non-limiting example, a promoter can be present in a nucleic acid construct in combination with one or more regulatory elements and / or coding sequences that are not naturally associated with that particular promoter, i.e., they are heterologous to the promoter.

[0071] "Isolated" nucleic acid molecules or nucleotide sequences or "isolated" polypeptides are nucleic acid molecules, nucleotide sequences or polypeptides that exist out of their natural environment by human hands and / or have different, modified, regulated and / or altered functions when compared to their functions in their natural environment and are therefore not natural products. Isolated nucleic acid molecules or isolated polypeptides can exist in purified form or can exist in a non-natural environment (such as, for example, a recombinant host cell). Thus, for example, with respect to a polynucleotide, the term isolated means that the polynucleotide is separated from the chromosome and / or cell in which it naturally exists. If a polynucleotide is separated from the chromosome and / or cell in which it naturally exists and then inserted into a genetic background, chromosome, chromosomal position, and / or cell in which it does not naturally exist, the polynucleotide is also isolated. Recombinant nucleic acid molecules and nucleotide sequences of the present invention can be considered to be "isolated" as defined above.

[0072] Thus, an "isolated nucleic acid molecule" or "isolated nucleotide sequence" is a nucleic acid molecule or nucleotide sequence that is not adjacent to a nucleotide sequence adjacent thereto (either a sequence located at the 5' end or a sequence located at the 3' end) in the naturally occurring genome of the organism from which it is derived. Thus, in one embodiment, an isolated nucleic acid includes some or all of the 5' non-coding (e.g., promoter) sequences that are directly adjacent to the translation start site or transcription start site of the coding sequence. Thus, the term includes, for example, a recombinant nucleic acid that is incorporated into a vector, into a self-replicating plasmid or virus, or into the genomic DNA of a prokaryote or eukaryote, or that exists as a separate molecule (e.g., a cDNA or a genomic DNA fragment obtained by PCR or restriction endonuclease treatment) independent of other sequences. It also includes a recombinant nucleic acid that is part of a hybrid nucleic acid molecule encoding an additional polypeptide or peptide sequence. An "isolated nucleic acid molecule" or "isolated nucleotide sequence" may also include a nucleotide sequence that is derived from and inserted into the same natural original cell type, but is present in a non-natural state, for example, in a different copy number, and / or under the control of regulatory sequences that are different from those found in the natural state of the nucleic acid molecule.

[0073] The term "isolated" may further refer to a nucleic acid molecule, nucleotide sequence, polypeptide, peptide or fragment that is substantially free of cellular material, viral material, and / or culture medium (e.g., when produced by recombinant DNA techniques), or chemical precursors or other chemicals (e.g., when chemically synthesized). Additionally, an "isolated fragment" is a fragment of a nucleic acid molecule, nucleotide sequence or polypeptide that does not naturally exist as a fragment and would not so exist in nature. "Isolated" does not necessarily mean that the preparation is industrially pure (homogeneous), but it is sufficiently pure to provide the polypeptide or nucleic acid in a form that can be used for the intended purpose.

[0074] In representative embodiments of the invention, "isolated" nucleic acid molecules, nucleotide sequences and / or polypeptides have a purity (w / w) of at least about 5%, 10%, 15%, 20%, 25%, 30%, 40%, 50%, 60%, 70%, 75%, 80%, 85%, 90%, 95%, 97%, 98%, 99% or more. In other embodiments, "isolated" nucleic acids, nucleotide sequences and / or polypeptides represent at least about 5-fold, 10-fold, 25-fold, 100-fold, 1000-fold, 10,000-fold, 100,000-fold or greater enrichment (w / w) of the nucleic acid compared to the starting material.

[0075] In the context of plant cells, plants and / or plant parts, the term "introducing" (introducing or introducing) means that a nucleic acid molecule contacts a plant, a plant part and / or a plant cell in such a way that the nucleic acid molecule enters the interior of a plant cell and / or a cell of a plant and / or a plant part. In the case of introducing more than one nucleic acid molecule, these nucleic acid molecules can be assembled into a part of a single polynucleotide or nucleic acid construct, or assembled into separate polynucleotides or nucleic acid constructs, and can be located on the same or different nucleic acid constructs. Therefore, these polynucleotides can be introduced into plant cells in a single transformation event, in a separate transformation event, or, for example, as part of a breeding program. Therefore, the term "transformation" used herein refers to the introduction of a heterologous nucleic acid into a cell. The transformation of a cell can be stable or transient. Therefore, transgenic plant cells, plants and / or plant parts of the present invention can be stably transformed or transiently transformed.

[0076] The term "percentage of sequence identity" or "percentage of identity" is used interchangeably herein, and is used herein to refer to the percentage of identical nucleotides or amino acids in a linear polynucleotide sequence or amino acid of a reference ("query") sequence (or its complementary strand) compared to a test ("subject") sequence (or its complementary strand) when two sequences are optimally aligned. The optimal sequence alignment for comparing a comparison window is known to those skilled in the art and can be performed using known methods, such as using known software or computer programs, such as using the default matrix file EBLOSUM62 for proteins, using the Smith and Waterman algorithm implemented in the EMBOSS-6.6.0 water tool of EDNAFULL (default gap penalty) for DNA. EMBOSS-6.6.0 is available from, for example, the following Bio-soft and Open-Bio, such as the following website: en.bio-soft.net / format / emboss.html or emboss.open-bio.org / html / adm / ch01s01.html.

[0077] The terms "nucleic acid" or "polynucleotide" are used interchangeably herein and refer to any physical string of monomeric units that can correspond to a series of nucleotides, including polymers of nucleotides (e.g., typical DNA polymers or polydeoxyribonucleotides or RNA polymers or polyribonucleotides), modified oligonucleotides (e.g., oligonucleotides containing bases that are not typical of biological RNA or DNA, such as 2'-O-methylated oligonucleotides), etc. In some embodiments, nucleic acids or polynucleotides can be single-stranded, double-stranded, multi-stranded, or a combination thereof. Unless otherwise indicated, in addition to any explicitly indicated polynucleotides, a specific nucleic acid or polynucleotide of the present invention optionally also contains or encodes a complementary polynucleotide. The nucleic acid can be present in a vector, such as a cell, a virus, or a plasmid.

[0078] "Operably linked" refers to the association of polynucleotides on a single nucleic acid fragment such that the function of one affects the function of the other. For example, a promoter is operably linked to a coding polynucleotide when the promoter is capable of affecting the expression of the coding polynucleotide (i.e., the coding polynucleotide is under the transcriptional control of the promoter). A coding polynucleotide in either the sense or antisense orientation can be operably linked to a regulatory polynucleotide.

[0079] The term "plant" refers to any plant, particularly an agronomically useful plant (e.g., a seed plant), and a "plant cell" is a structural and physiological unit of the plant (including a cell wall), and may also refer to a protoplast. The plant cell may be in the form of an isolated single cell or a cultured cell, or as part of a higher organized unit (such as, for example, a plant tissue, or a plant organ differentiated into structures present at any stage of plant development). The plant may be a monocot or a dicot species.

[0080] A "plant cell" is a structural and physiological unit of a plant, comprising a protoplast and a cell wall. A plant cell may be in the form of an isolated single cell or a cultured cell, or as part of a higher organized unit such as, for example, a plant tissue, a plant organ, or a whole plant.

[0081] As used herein, the term "plant part" includes, but is not limited to, embryos, pollen, ovules, seeds, leaves, stems, buds, flowers, branches, fruits, kernels, ears, cobs, husks, stalks, roots, root tips, anthers, plant cells intact in plants and / or plant parts, plant protoplasts, plant tissues, plant cell tissue cultures, plant callus, plant masses, etc. As used herein, "buds" refer to the above-ground parts including leaves and stems. In addition, as used herein, "plant cells" refer to the structural and physiological units of plants, including cell walls and may also refer to protoplasts. The plant cells of the present invention may be in isolated unicellular form, or may be cultured cells, or may be part of a higher organizational unit (such as, for example, plant tissues or plant organs).

[0082] As used herein, "plant tissue" refers to a group of plant cells organized into structural and functional units. Any plant tissue in a plant or in culture is included. This term includes, but is not limited to, whole plants, plant organs, plant seeds, tissue cultures, and any group of plant cells organized into structural and / or functional units. The use of this term in conjunction with or alone any specific type of plant tissue as listed above or otherwise covered by this definition is not intended to exclude any other type of plant tissue.

[0083] As used herein, the term "promoter" refers to a polynucleotide generally located upstream (5') of the translation start site of a coding sequence, which controls the expression of the coding sequence by providing recognition of RNA polymerase and other factors required for correct transcription. For example, a promoter may contain a region comprising a basic promoter element recognized by RNA polymerase, a region containing a 5' untranslated region (UTR) of a coding sequence, and optionally an intron. In some embodiments, a promoter comprises or consists of a region of about 2 kb upstream (5') of the translation start site of a known or predicted coding sequence.

[0084] "Regulatory elements" and "regulatory sequences" are used interchangeably herein and refer to nucleotide sequences located upstream (5' non-coding sequences), internal or downstream (3' non-coding sequences) of a coding sequence, which affect the transcription, RNA processing or stability or translation of the associated coding sequence. Regulatory sequences include enhancers, promoters, translation enhancer sequences, introns, terminators and polyadenylation signal sequences. They include natural sequences and synthetic sequences, together with sequences that may be combinations of synthetic sequences and natural sequences. Regulatory sequences can determine expression levels, spatial patterns and temporal patterns of expression, and for a subset of promoters, determine expression under inductive conditions (regulated by external factors, such as light, temperature, chemicals and hormones). Regulatory sequences can be short regions of 6-100 base pairs of DNA sequences that define binding sites for trans-acting factors such as transcription factors. Regulatory sequences can also be enhancers, i.e. longer regions of DNA sequences that can play a role at a distance from the core promoter region (sometimes more than a few thousand bases from the core region). Regulatory sequence activity can be influenced by trans-acting factors, including the general transcription machinery, transcription factors, and chromatin assembly factors.

[0085] As used herein, "terminator" is responsible for the transcription termination and correct mRNA polyadenylation beyond the translation termination site of the coding sequence. The terminator region may be naturally together with the transcription initiation region, may be naturally together with the DNA sequence operably connected to the purpose, may be naturally together with the host plant, or may be derived from another source (i.e., foreign or heterologous to the promoter, the target DNA sequence, the host plant, or any combination thereof). Suitable transcription terminators are those known to play a role in plants, and include CAMV 35S terminator, tml terminator, nopaline synthase terminator, and pea rbcs E9 terminator. These terminators can be used in both monocots and dicots. In addition, the natural transcription terminator of a gene can be used. For example, the terminator may contain a 3' untranslated region (UTR) comprising a coding sequence and optionally an additional 3' non-transcribed sequence region. In certain embodiments, the terminator comprises or consists of a region of about 1 kb downstream (3') of the translation termination site of a known or predicted coding sequence.

[0086] "Selectable marker" or "selectable marker gene" refers to a gene, the expression of which in a plant cell gives the cell a selective advantage. "Positive selection" refers to a transformed cell, which obtains a substrate metabolic ability that it could not use or could not use effectively before, typically by transforming and expressing a positive selective marker gene. The cells of this transformation grow out of a large number of untransformed tissues. Positive selection can be many types of inactive forms from plant growth regulators, which are then converted to active forms by the transferred enzyme to transform carbohydrate sources, which are not effectively used by non-transformed cells (such as mannose), and then enzymes such as phosphomannose isomerase can be obtained after transformation to enable them to be metabolized. Compared with transformed cells, non-transformed cells grow slowly or do not grow at all. Compared with non-transformed cell growth ability, other types of selection may be due to cell transformation with a selective marker gene, which obtains the ability to grow in the presence of a negative selection agent (such as an antibiotic or herbicide). The selective advantage possessed by transformed cells can also be due to the loss of previously possessed genes in the so-called "negative selection". In this case, the added compound is toxic only to cells that have not lost the specific gene (negative selectable marker gene) present in the parental cell (usually a transgenic).

[0087] Examples of selectable markers include, but are not limited to, genes that provide resistance or tolerance to antibiotics such as kanamycin (Dekeyser et al. 1989, Plant Phys 90:217-23), spectinomycin (Svab and Maliga 1993, Plant Mol Biol 14:197-205), streptomycin (Maliga et al. 1988, Mol Gen Genet 214:456-459), hygromycin B (Waldron et al. 1985, Plant Mol Biol 5:103-108), bleomycin (Hille et al. 1986, Plant Mol Biol 7:171-176), sulfonamides (Guerineau et al. 1990, Plant Mol Biol 15:127-136), streptothricin (Jelenska et al. 2000, Plant Cell Biol 15:137-139), and thiothreitol (Hilson et al. 1993, Plant Mol Biol 15:143-147). Rep [Plant Cell Reports] 19:298-303), or chloramphenicol (De Block et al. 1984, EMBO J [Journal of the European Molecular Biology Association] 3:1681-1689).Other selectable markers include genes that provide resistance or tolerance to herbicides, such as S4 and / or Hra mutations of acetolactate synthase (ALS) that confer resistance to herbicides including sulfonylureas, imidazolinones, triazolopyrimidines, and pyrimidinylthiobenzoates; 5-enol-pyrrole-shikimate-3-phosphate synthase (EPSPS) genes, including but not limited to those described in U.S. Pat. Nos. 4,940,935, 5,188,642, 5,633,435, 6,566,587, 7,674,598 (link); with all related applications), and glyphosate N-acetyltransferase (GAT), which confers resistance to glyphosate (Castle et al. 2004, Science 304: 1151-1154, and U.S. Patent Application Publication Nos. 20070004912, 20050246798, and 20050060767); BAR, which confers resistance to glufosinate (see, e.g., U.S. Patent No. 5,561,236); aryloxyalkanoate dioxygenase (ARS), which confers resistance to glufosinate (see, e.g., U.S. Patent No. 5,561,236); dioxygenase) or AAD-1, AAD-12, or AAD-13, which confer resistance to 2,4-D; genes (such as Pseudomonas HPPD) that confer resistance to HPPD; Sprotophorphyrinogen oxidase (PPO) mutants and variants that confer resistance to peroxidic herbicides, including fomesafen, acifluorfen sodium, oxyfluorfen, lactofen, fluthiazol-butyl, pyrimidinesulfuron, fluazifop-butyl, fluazifop-butyl, mesotrione, and sulfentrazone; and genes that confer resistance to dicamba, such as dicamba monooxygenase (Herman et al. 2005, J Biol Chem [Journal of Biological Chemistry] 280:24759-24767 and U.S. Pat. No. 7,812,224, and related applications and patents). Other examples of selectable markers can be found in Sundar and Sakthivel (2008, J Plant Physiology 165: 1698-1716), which is incorporated herein by reference.

[0088] Other selection systems include the use of drugs, metabolite analogs, metabolic intermediates and enzymes for positive selection or conditional positive selection of transgenic plants. Examples include, but are not limited to, genes encoding phosphomannose isomerase (PMI) in which mannose is a selection agent, or genes encoding xylose isomerase in which D-xylose is a selection agent (Haldrup et al. 1998, Plant Mol Biol [Plant Molecular Biology] 37: 287-96). Finally, other selection systems can use hormone-free culture media as selection agents. A non-limiting example is the corn homeobox gene kn1, whose ectopic expression results in a 3-fold increase in transformation efficiency (Luo et al. 2006, Plant Cell Rep [Plant Cell Report] 25: 403-409). Examples of various selective markers and genes encoding them are disclosed in Miki and McHugh (J Biotechnol [Biological Technology Magazine], 2004, 107: 193-232; incorporated by reference).

[0089] In some embodiments of the present disclosure, the selective marker can be plant-derived. Examples of plant-derived selective markers include, but are not limited to, 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS). The enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) catalyzes an important step in the common shikimate pathway of aromatic amino acid biosynthesis in plants. The herbicide glyphosate inhibits EPSPS, thus killing plants. Transgenic glyphosate-tolerant plants can be produced by introducing a modified EPSPS transgene that is not affected by glyphosate (e.g., U.S. Patent No. 6,040,497; incorporated by reference). Other examples of modified plant EPSPS that can be used as a selective marker in the presence of glyphosate include the P106L mutation of rice EPSPS (Zhou et al. 2006, Plant Physiol [Plant Physiology] 140: 184-195) and the P106S mutation in cricket grass EPSPS (Baerson et al. 2002, Plant Physiol [Plant Physiology] 129: 1265-1275). Other sources of EPSPS that are not plant-derived and can be conferred with glyphosate tolerance include, but are not limited to, the EPSPS P101S mutation from Salmonella typhimurium (Comai et al. 1985, Nature 317:741-744) and a mutant version of the CP4 EPSPS from CP4 of an Agrobacterium strain (Funke et al. 2006, PNAS 103:13010-13015). Although plant EPSPS genes are nuclear, the mature enzyme is located in the chloroplast (Mousdale and Coggins 1985, Planta 163:241-249). EPSPS is synthesized as a preprotein containing a transit peptide, which is then transported to the chloroplast stroma and proteolytically hydrolyzed to produce the mature enzyme (della-Cioppa et al. 1986, PNAS 83:6873-6877). Therefore, in order to produce the transgenic plant with tolerance to glyphosate, the appropriate mutant form of the EPSPS that correctly translocates to chloroplast can be introduced.Then this type of transgenic plant has natural, genomic EPSPS gene, together with the EPSPS transgenic of sudden change.Then glyphosate can be used as the selective agent in conversion and regeneration process, thus only survives those plants or plant tissues that successfully transform with the EPSPS transgenic of sudden change.

[0090] As used herein, the term "transformation" refers to the transfer of a nucleic acid into a host cell, preferably resulting in genetically stable integration, including integration into chromosomes and heritable extrachromosomal events. In some specific embodiments, the introduction into plants, plant parts and / or plant cells is via bacterial-mediated transformation, particle bombardment transformation (also known as gene gun particle transformation), calcium phosphate-mediated transformation, cyclodextrin-mediated transformation, electroporation, liposome-mediated transformation, nanoparticle-mediated transformation, polymer-mediated transformation, virus-mediated nucleic acid delivery, whisker-mediated nucleic acid delivery, microinjection, sonication, infiltration, polyethylene glycol-mediated transformation, protoplast transformation, or any other electrical, chemical, physical and / or biological mechanism that results in the introduction of nucleic acids into plants, plant parts and / or cells thereof, or a combination thereof. General guides to the various plant transformation methods known in the art include Miki et al. ("Procedures for Introducing Foreign DNA into Plants," in Methods in Plant Molecular Biology and Biotechnology), Glick, BR and Thompson, JE, eds. (CRC Press, Inc., Boca Raton, 1993, pp. 67-88), and Rakowoczy-Trojanowska (2002, Cell. Mol. Biol. Lett. 7:849-858 (2002)).

[0091] Procedures for transforming plants are well known and routine in the art and are generally described in the literature. Non-limiting examples of methods for plant transformation include transformation via bacterial-mediated nucleic acid delivery (e.g., via bacteria from the genus Agrobacterium), viral-mediated nucleic acid delivery, silicon carbide or nucleic acid whisker-mediated nucleic acid delivery, liposome-mediated nucleic acid delivery, microinjection, microparticle bombardment, calcium phosphate-mediated transformation, cyclodextrin-mediated transformation, electroporation, nanoparticle-mediated transformation, sonication, infiltration, PEG-mediated nucleic acid absorption, and any other electrical, chemical, physical (mechanical) and / or biological mechanism that allows nucleic acid to be introduced into plant cells, including any combination thereof. A general guide to various plant transformation methods known in the art includes Miki et al. ("Procedures for Introducing Foreign DNA into Plants" in Plant Molecular Biology and Biotechnologyin the methods of [Plant Molecular Biology and Biotechnology], edited by Glick, B.R. and Thompson, J.E. (CRC Press, Inc., Boca Raton, 1993, pp. 67 - 88) and Rakowoczy - Trojanowska (Cell. Mol. Biol. Lett. 7:849 - 858 (2002)).

[0092] Agrobacterium - mediated transformation is a commonly used method for transforming plants because of its high transformation efficiency and its broad utility with many different species. Agrobacterium - mediated transformation typically involves transferring a binary vector carrying the foreign DNA of interest to an appropriate Agrobacterium strain, which may depend on the complement of vir genes carried by the host Agrobacterium strain either on a co - resident Ti plasmid or chromosomally (Uknes et al. 1993, Plant Cell 5:159 - 169). Transfer of this recombinant binary vector to Agrobacterium can be achieved using Escherichia coli carrying the recombinant binary vector and a helper E. coli strain (the helper strain carrying a plasmid capable of mobilizing the recombinant binary vector into the target Agrobacterium strain) by a tri - parental mating procedure. Alternatively, the recombinant binary vector can be transferred into Agrobacterium by nucleic acid transformation ( and Willmitzer, 1988, Nucleic Acids Res. 16:9877).

[0093] Plant transformation by recombinant Agrobacterium usually involves co - culturing Agrobacterium with an explant from the plant and follows methods well - known in the art. Typically, transformed tissue is regenerated on a selection medium carrying an antibiotic or herbicide resistance marker located between the T - DNA borders of these binary plasmids.

[0094] Another method for transforming plants, plant parts, and plant cells involves propelling inert or biologically active particles onto plant tissues and cells. See, for example, U.S. Patent Nos. 4,945,050; 5,036,006 and 5,100,792. Generally, this method involves propelling inert or biologically active particles at plant cells under conditions effective to penetrate the outer surface of the cell and provide incorporation within it. When using inert particles, the vector can be introduced into the cell by coating the particles with a vector containing the nucleic acid of interest. Alternatively, one or more cells can be surrounded by the vector such that the vector is brought into the cell by the excitation of the particle. Biologically active particles (e.g., dried yeast cells, dried bacteria, or phage, each containing one or more nucleic acids to be introduced) can also be propelled into plant tissues.

[0095] Thus, in certain embodiments of the invention, plant cells can be transformed by any method known in the art and as described herein and whole plants can be regenerated from these transformed cells using any of a variety of known techniques. Plant regeneration from plant cells, plant tissue cultures, and / or cultured protoplasts is described in, for example, Evans et al. ( Handbook of Plant Cell Cultures Plant Cell Culture Manual, Vol. 1, MacMilan Publishing Co., New York (1983); and Vasil I.R. (ed.) ( Cell Culture and Somatic Cell Genetics of Plants [Plant Cell Culture and Somatic Cell Genetics], Acad. Press, Orlando, Vol. I (1984) and Vol. II (1986). Methods for selecting transformed transgenic plants, plant cells and / or plant tissue cultures are routine in the art and can be used in the methods of the invention provided herein.

[0096] A "transgenic plant" is a plant having one or more plant cells containing a heterologous DNA sequence.

[0097] As used herein, "vector" includes and refers to a nucleic acid used to transfect a host cell and into which a polynucleotide can be inserted. A vector is often a replicon. An expression vector allows transcription of a nucleic acid inserted therein. "Vector" is defined as including, among others, any plasmid, cosmid, phage or Agrobacterium binary vector in a double-stranded or single-stranded linear or circular form, which may or may not be self-transmissible or mobile, and which can transform a prokaryotic or eukaryotic host (e.g., an autonomous replicating plasmid with a replication origin) by integrating into the genome of the cell or existing outside the chromosome. Particularly included are shuttle vectors, the term shuttle vector meaning a DNA vector that is naturally or designed to replicate in two different host organisms, which host organisms can be selected from: actinomycetes and related species, bacteria and eukaryotic organisms (e.g., higher plants, mammals, yeast or fungal cells). DETAILED DESCRIPTION

[0098] Some aspects of the disclosure relate to regulatory elements, such as promoters and terminators, for expression of heterologous sequences in plants, such as soybean.

[0099] In some aspects, the disclosure provides a nucleotide sequence having at least 90% identity (e.g., at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% identity) to one or more of SEQ ID NOs: 1-30, such as 1-5 or 8-29. In some embodiments, the nucleotide sequence comprises one or more of SEQ ID NOs: 1-30, such as 1-5 or 8-29. In some embodiments, the nucleotide sequence comprises one of SEQ ID Nos: 1-30, such as 1-5 and one of SEQ ID Nos: 8-29. In some embodiments, the disclosure provides nucleotide sequences comprising fragments of one or more of SEQ ID NOs: 1-30, such as 1-5 or 8-29, e.g., biologically active fragments (e.g., fragments of at least 100, at least 200, at least 300, at least 400, at least 500, at least 600, at least 700, at least 800, at least 900, or at least 1000 consecutive nucleotides of SEQ ID NOs: 1-30, such as 1-5 or 8-29). In some embodiments, the disclosure provides nucleotide sequences comprising fragments of one or more of SEQ ID NOs: 1-30, such as 1-5 or 8-29, e.g., biologically active fragments (e.g., fragments of at least 100, at least 200, at least 300, at least 400, at least 500, at least 600, at least 700, at least 800, at least 900, or at least 1000 consecutive nucleotides of SEQ ID NOs: 1-30, such as 1-5 or 8-29).

[0100] In some aspects, the disclosure provides expression cassettes. In some embodiments, the expression cassette comprises a nucleotide sequence having at least 90% identity (e.g., at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99% or 100% identity) with SEQ ID NO: 1-30, such as one or more of 1-5 or 8-29, wherein the nucleotide sequence is operably linked to a heterologous nucleotide sequence. In some embodiments, the expression cassette comprises a nucleotide sequence containing SEQ ID NO: 1-30, such as one of 1-5 or 8-29. In some embodiments, the expression cassette comprises a nucleotide sequence containing SEQ ID NO: 1-30, such as one of 1-5 and one of 8-29. In some embodiments, the expression cassette comprises a nucleotide sequence comprising a fragment of one or more of SEQ ID NOs: 1-30, such as 1-5 or 8-29, such as a biologically active fragment (e.g., a fragment of at least 100, at least 200, at least 300, at least 400, at least 500, at least 600, at least 700, at least 800, at least 900, or at least 1000 consecutive nucleotides of one or more of SEQ ID NOs: 1-30, such as 1-5 or 8-29). In some embodiments, the expression cassette further comprises a selectable marker.

[0101] In some embodiments, the heterologous sequence is a target nucleic acid encoding a target RNA or protein. In some embodiments, the target RNA or protein can confer desirable characteristics to plants, such as antibiotic resistance, virus resistance, insect resistance, disease resistance, resistance to other harmful organisms, herbicide tolerance, improved nutritional value, improved performance in industrial processes, or altered reproductive capacity. In some embodiments, the target RNA or protein comprises a genome editing agent, such as a CRISPR / Cas agent (such as a Cas protein and / or a guide RNA), a TALEN, a DNA-guided nuclease, a meganuclease, a recombinase, or a zinc finger nuclease. In some embodiments, the heterologous nucleotide sequence encodes a selective marker.

[0102] In some embodiments, the expression cassette is contained in a vector, such as a plasmid, a virus, or an Agrobacterium. In some embodiments, the expression cassette is contained in a plant cell. In some embodiments, the plant cell is a dicotyledonous plant cell. In some embodiments, the plant cell is a soybean cell. In some embodiments, the soybean cell is an elite soybean cell.

[0103] In some embodiments, the expression cassette is contained in a transgenic plant. In some embodiments, the plant is a dicot. In some embodiments, the plant is a soybean plant. In some embodiments, the soybean plant is an elite soybean plant.

[0104] In some embodiments, the disclosure provides seeds from a transgenic plant, eg, seeds comprising the expression cassette.

[0105] In some embodiments, the disclosure provides a commodity produced by a transgenic plant or part thereof, e.g., a commodity comprising the expression cassette. In some embodiments, the commodity is selected from the group consisting of: whole or processed seeds, flour, protein isolate, concentrate, liquid, syrup, paste, sauce or other food or product.

[0106] Other aspects of the present disclosure relate to a method, such as a transformation method, which includes introducing an expression cassette or vector as described herein into a plant or plant cell. In some embodiments, the introduction includes Agrobacterium-mediated transformation. In some embodiments, the introduction includes particle bombardment. In some embodiments of the method, the method further includes placing the plant or plant cell under conditions where the expression cassette or vector expresses the target RNA or protein and / or a selective marker. In some embodiments, these conditions are suitable growth or maintenance conditions for the plant or plant cell. In some embodiments of the method, the method further includes hybridizing the plant with a second plant to produce a progeny plant. In some embodiments of the method, the method further includes selfing the plant to produce a progeny plant. In some embodiments, the plant or plant cell is a dicotyledonous plant or plant cell. In some embodiments, the plant or plant cell is a soybean plant or plant cell. In some embodiments, the plant or plant cell is an excellent soybean plant or plant cell. In some embodiments, the second plant is an excellent soybean plant.

[0107] Hereinafter, the present invention will be described in detail by the following examples. However, the following examples are for illustration of the present invention, and the scope of the present invention is not limited by the following examples.

[0108] Examples

[0109] Example 1: Identification and characterization of novel promoter sequences

[0110] method

[0111] Candidate promoter sequences were obtained using reference genomes from wild Glycine max species (Glycine max, Glycine max, Glycine max penghuensis, and Glycine max seu ...uc t o r s (Ubi), S-adenosylmethionine (SAM), actin depolymerizing factor (ADF3), and translation elongation factor EF-1α (EF1a). Additional candidate promoter sequences were identified using RNAseq data to identify genes expressed between 12-18 log2 normalized data in soybean, and putative promoter sequences from these genes were added as candidates. Candidate promoter sequences are 2 kb regions upstream of predicted or known translation start sites. Candidate promoter sequences are expected to contain basal promoter elements, as well as 5'UTR and possible introns (depending on the structure of the predicted or known coding sequence).

[0112] Vectors were designed for each candidate promoter, each containing soybean codon-optimized Bx9, maize UDP-glucosyltransferase, benzoxazine 9 (for a description of maize Bx9, see International Publication No. WO 2018213022), as a reporter gene, and terminator sequence tMt51186 (SEQ ID NO: 30). For ease of cloning, mutations were made in the promoter sequence to remove any NcoI and SacI sites. ATG in the 5'UTR was also mutated.

[0113] First, the vectors were screened by transient transformation. All vectors were compared with the average expression level of the vector containing the baseline positive control promoter (prGmSAMS, SEQ ID NO:7). 14-day-old soybean plants were used for transient transformation. A wire brush was used to damage the abaxial surface of the first group of three leaves. The plant leaves were then immersed in an Agrobacterium solution containing a test construct and an internal control construct (ratio of 1:1). Each Agrobacterium was adjusted to OD=1.0 at 600nm. The immersed plants were placed in a vacuum chamber and vacuum was applied for 3-5 minutes. The infiltrated plants were placed in a tray with a transparent plastic cover to maintain humidity. Four days after infiltration, the infiltrated leaves were sampled in a 96-well block for ELISA determination. ELISA used two polyclonal antibodies produced against BX9 protein. At 4°C, high binding polystyrene plates (Nunc Maxisorp #430341) were coated with 10 μg / ml goat anti-BX9 in 25 mM borate, 75 mM NaCl, pH 8.5 overnight. The plates were washed five times with phosphate buffered saline + 0.05% Tween-20 (PBST). Standards (160, 80, 40, 20, 10, 5, 2.5 and 0 ng / ml of purified BX9 protein) were prepared in ELISA diluent (PBST + 1% bovine serum albumin). 100 microliters of each appropriately diluted sample or standard was added to the plate, incubated at 200 rpm for 1 hour at ambient temperature, and washed five times. Rabbit anti-BX9 (100 μl / well) diluted to 1 μg / ml in ELISA diluent was then added to the plate, incubated at 200 rpm for 1 hour at ambient temperature, and washed as described above. Donkey anti-rabbit (Jackson ImmunoResearch, West Grove, Pennsylvania) conjugated to alkaline phosphatase was added to the plate (100 μl / well) at 1 μg / ml in ELISA diluent, incubated with 200 rpm shaking at ambient temperature, and washed. Substrate p-nitrophenyl phosphate (Surmodics, Eden Prairie, Minnesota) was added and allowed to develop at room temperature for 15-30 minutes. Absorbance was measured at 405 nm using a microplate reader (BioTek Powerwave XS2, Winooski, Vermont). The standard curve was plotted using a four-parameter curve fit to plot concentration versus absorbance. To normalize the extraction efficiency, the analyte (BX9) concentration was divided by the total soluble protein (TSP) concentration. TSP was measured using the Pierce™ BCA (bicinchoninic acid) protein assay (ThermoFisher Scientific).

[0114] Based on the data generated, a vector containing prGaSAMS599400 (see Table 1) was chosen as a negative control for additional studies.

[0115] Then select a subset of the vector and stably transform it into soybean plants and verify it in T0 and T1 events and compare it with positive and negative controls. Soybean (soybean (Glycine max), variety 06KG212440) seeds are sterilized overnight with chlorine. The sterilized seeds are immersed in germination medium (SoyGerm) with the hilum facing down. The seeds are incubated in the dark at 22°C-24°C for about 16 hours. As described in International Publication No. WO 2004000006, explants are prepared using infiltrated seeds. The immature seed explants separated are inoculated with infection medium (SoyInf: 1 The prepared explants are immediately infected with the harmless Chry5d3 Agrobacterium tumefaciens strain containing the respective binary vector by mixing with a bacterial suspension in 1x 2x MS salts, 1x B5 vitamins, 2g / L sucrose, 1g / L glucose, 4g / L MES [2-(N-morpholino)ethanesulfonic acid], 2mg / L zeatin riboside and 200μM acetosyringone, pH 5.4). The mixture is incubated at room temperature for at least 30 minutes or overnight. After infection, the explants are removed from the Agrobacterium suspension and placed in a co-cultivation medium, such as SoyCCM 2Zt ( 1 / 2x MS salts, 1x B5 vitamins, 2g / L sucrose, 1g / L glucose, 4g / L MES, 2mg / L zeatin riboside and 200μM acetosyringone, pH 5.4, containing 6g / L purified agar), preferably with the adaxial (flat) side facing up. The co-cultivation plates are incubated at 23°C in the dark for 3 to 5 days.

[0116] After co-cultivation, the elongated hypocotyl of the explant is trimmed to just below the cotyledon node. The explant is transferred to a recovery medium without a selection agent, such as SoyRO (3.1g / L B5 salts, 1x B5 vitamins, 0.8x MS iron, 3% sucrose, 1g / LMES, 2mg / L BAP, 0.1g / L asparagine, 50mg / L timentin, 200mg l-1 cefotaxime and 50mg / L vancomycin, 7g / L agar, pH 5.7) (with appropriate antibiotics to inhibit the growth of Agrobacterium). The cotyledon node end is inserted into the culture medium. The plate with the explant is hatched for about 7-10 days at 24 degrees Celsius, in a scheme of 16 hours of light / 8 hours of darkness and>80μE / m2 / s.

[0117] After the recovery period, the explants and cotyledons are transferred to a regeneration medium, such as SoyR1 (3.1 g / L B5 salts, 1x B5 vitamins, 0.8x MS iron, 3% sucrose, 1 g / L MES, 2 mg / L BAP, 0.1 g / L asparagine, 7 g / L purified agar, pH 5.7, and an appropriate selection agent, such as ALS herbicide or glyphosate), for about 2-3 weeks. After about 2-3 weeks in regeneration / selection medium (such as SoyR1), the developed multiple shoot clusters are transferred to elongation medium SoyE1 (1x MS basal salts, 1x B5 vitamins, 0.8xMS iron, 3% sucrose, 0.6g / L MES, 50mg / L asparagine, 100mg / L glutamic acid, 0.1mg / L IAA, 0.5mg / L GA3, 1mg / L zeatin riboside, 50mg / L ticarcillin, 75mg / L cefotaxime, pH 5.7, solidified with 0.7% agar, and appropriate selection agents, such as ALS herbicides or glyphosate) to elongate the shoots. Fresh elongation medium SoyE1 is subcultured every 2-4 weeks until the elongated shoots (>3cm) are large enough to be transferred to soil for direct rooting in trays in non-porous secondary trays filled with water to keep the soil moist. The plastic domes were removed after approximately 2 weeks and leaves were sampled for Taqman analysis to identify plants positive for the gene of interest.

[0118] result

[0119] 31 vectors containing 31 different candidate promoters were tested in transient transformation assays. Of these 31, 5 were found to have comparable or better expression levels than a positive control promoter known to have high constitutive expression (see Table 1). The promoter prGaSAMS599400, which had poor expression relative to the control in the assay, was selected as a negative control in the stable transformation assay.

[0120] Table 1. Results of promoter transient transformation expression assay

[0121]

[0122] Then, the four candidate promoters shown in Table 1 to have better activity compared to the positive control were tested in the stable transformation assay.

[0123] In both transient and T0 events, four candidate promoters were shown to drive higher Bx9 expression in seedling leaves compared to the positive control (see Table 2, T0 data are from single copy events).

[0124] Table 2. Reporter expression in seedling leaves

[0125]

[0126] Table 2 (continued)

[0127]

[0128] Table 2 (continued)

[0129]

[0130]

[0131] The four candidate promoters were also shown to drive higher Bx9 expression in T1 seedling leaves compared to the positive control (see Figure 1 The four candidate promoters were also shown to drive higher Bx9 expression in T1 mature leaves and T1 roots during the reproductive stage compared to the positive control (see Figure 2 and 3 The four candidate promoters were also shown to drive higher or comparable Bx9 expression in T1 seed pods compared to the positive control (see Figure 4 Three of the four candidate promoters were also shown to drive higher or comparable Bx9 expression in T1 embryos compared to the positive control (see Figure 5 ). The promoter prGaUbiPI599400 was modified to generate prGaUbiPI599400-02, which drove expression of cCP4EPSPSCTP2-01 at acceptable levels. Additional data showing comparisons between promoters at different stages are shown in Table 3 below.

[0132] Table 3. Comparison of promoters at the construct level

[0133]

[0134] Table 3 (continued)

[0135]

[0136]

[0137] In summary, these data show that the four selected candidate promoters are highly expressed in a variety of tissues and are expected to be useful as constitutive promoters for use in expression constructs in soybean. Example 2: Identification and Characterization of Novel Terminator Sequences

[0138] method

[0139] Candidate terminator sequences are derived from the genes tested in Example 1 and tested for terminator activity. Candidate terminator sequences are 1 kb regions downstream of predicted or known translation stop sites. Candidate terminator sequences are expected to contain 3'UTR and possibly additional 3' non-transcribed sequences (depending on the structure of the predicted or known coding sequence).

[0140] Vectors were designed for each candidate terminator, each containing Bx9 as a reporter gene and a promoter sequence prGmSAMS (SEQ ID NO: 7). The vectors were first screened by transient transformation using the method described in Example 1. All vectors were compared to the average expression level of a vector containing a baseline positive control terminator (tMt51186, SEQ ID NO: 30). Expression levels were measured by ELISA as described in Example 1.

[0141] A subset of vectors were then selected and stably transformed into soybean plants and verified in T0 and T1 events and compared to positive and negative controls. Transformation and analysis methods were identical to those described in Example 1.

[0142] result

[0143] Twenty-nine vectors containing 29 different candidate terminators were tested in transient transformation assays. Of these 29, 22 were found to have expression levels comparable to or better than a positive control terminator known to support high constitutive expression (see Table 4).

[0144] Table 4. Terminator transient transformation expression assay results

[0145]

[0146] Then, the six candidate terminators shown in Table 4 to have better activity compared to the positive control were tested in the stable transformation assay.

[0147] In both transient and T0 events, all six candidate terminators were shown to drive higher Bx9 expression in seedling leaves compared to the positive control (see Table 5, T0 data are from single copy events).

[0148] Table 5. Reporter expression in seedling leaves

[0149]

[0150] The six candidate terminators were also shown to drive higher or comparable Bx9 expression in T1 seedling leaves compared to the positive control (see Figure 6 The six candidate terminators were also shown to drive higher or comparable Bx9 expression in T1 mature leaves and T1 roots during the reproductive stage compared to the positive control (see Figure 7 and 8 The six candidate terminators were also shown to drive higher or comparable Bx9 expression in T1 seed pods compared to the positive control (see Fig. 9 Five of the six candidate terminators were also shown to drive higher or comparable Bx9 expression in T1 embryos compared to the positive control (see Fig.10). Additional data showing comparisons between promoters at different stages are shown in Table 6 below.

[0151] Table 6. Comparison of terminators at the construct level

[0152]

[0153] Table 6 (continued)

[0154]

[0155] Note: Mean values ​​are Bx9 expression in homozygous T1 plants (ng Bx9 / mg total soluble protein)

[0156] In summary, these data show that the six selected candidate terminators support high expression in multiple tissues and are expected to be useful in expression constructs in soybean. Sequence Listing <110> SYNGENTA CROP PROTECTION AG <120> Glycine regulatory elements and their uses <130> TBD <160> 31 <170> PatentIn version 3.5 <210> 1 <211> 2000 <212> DNA <213> Artificial sequence <220> <223> Synthetic polynucleotides <400> 1 aaaactttca catgaatagc acgaagaatc acaatgaacg attgatcttc ttttaaaatc 60 aaatattaat tgggaaataa aaaaataaaa aatggaagtt cacaatatag tgttcgtgtg 120 cttttcatga aaactgtttt tgtaactttc agcatttttc atataattag gtcatgttgg 180 gtataattag ctataaaatt agttaaaaat ttaaaaatta gttggtaact taaagttaaa 240 aagtaactta ttaattaaattattattaaaattaat tgttaaaata attgaaaagt 300 aaaataac aaaaaataat aaaaatta atttaatta gatactagg aaaataata 360 aaaaaaaaaaaaaaaaaaaahaaaaaaagttt taaaatgt taaaatag 420 ttaaaatta ttaaaaactt atttaaaa cagttaaatt aacaac tttcgctta 480 tgaaaataa aagcttacct aactttagta gatacttgt ccaaatta gttgatacct 540 attgccctta agttttctt attcatt attggttttg tcacaagct atcttttaat 600 cttaatttat tgtaaaaaa tccgtcgcct tcatttaca catctgctca 660 ttagaaaaat aaaatttctc ctaaacgatt agtagaaaaa atcattttaa taatgaataa 720 gaaagaata taggaaaaa attacktcat ttaaaaaaa cattttggatt atattttact 780 ttaaaatac taaatatttt taaatgacta attttatata cactgtact aaagtatac 840 aagttattat gttatgtatc aaagaat acttaaaaa tctactgaag atatcttac 900 aaaaaaaaaaaaaaaaaaaaaaaactg tgaaattt atgaattt tgaaaattg 960 aaaaaataat tattaaagaa tttagtggag tagaaagct ttccgatt tctttttttc 1020 catataaaa aaatctagca tgacagcttt tccatagatt ttaataatgt aaatactag 1080 tagcagccga ccgttcaggt aatggaccct ataaatttc gaacgctcca ctccacttgc 1140 aacgagtgcg ggccccaatt taatacgcc gtcgtacag ataaagtcca acgtgaagcg 1200 gtgaaggtgc atctctgact ccgtcagat tacgaaccg ctattacga aggactcccc 1260 gaaaatgcat ccaataccga atatcatgt gtgataagca ccaagtgaca ccatacatga 1320 gcacgcgtca caatgatt ggagaacagt tccaccat atgcttaaa atgcccccac 1380 acccctcgtc catcttcgca gttcattcc atcaattta gttcattctc ttgcgcagt 1440 tcctacctc tccattcaag gttcgtaaat ttttctgtt ttcttttt ctttttcg 1500 ttattgttg ttctcatca gcatgatgtt gatttgatg tgtctacat agtttcatcg 1560 aatctttatt ttcataatca gatcagctt ttattaatgc agaactttt ttaatggatg 1620 atttacaat cgtatattag gtctattag agtttttt cataaaaaat ttcagatccg 1680 tttacaacaa gccttaattt agattctgta gtcgtagatt agggtttttt ttttcattta 1740 ttacttcaga tccgttaaag aacagcctta tttgttgata cttcagtcgt ttttcaagaa 1800 attgtcagac cagttgaaaa aagcctgatt cgttgattct gtatagtttt tcaagagata 1860 ttgctcagat ctgttagcaa ctgccttatc tgttgattct atggccatag attaggggtt 1920 tttttctctc catgaaattg cttcttaaaa ctacgtgatg gattttgatt ctgatttatc 1980 tgtgattgtt gattctacag 2000 <210> 2 <211> 2000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 2 tacgaaaaac tttcacatga atagcacgaa gaatcacaat gaacgattga tcttatttta 60 aaaacaaata ttaattggga aataaaaaaa taaaaaatgg aagttcacaa tatagtgttc 120 gtgtgctttt catgaaaact gtttttgtaa ctttcagcat tttacatata attaggtcat 180 gttgggtata attagctata aaattagtta aaaatttaaa aatttgttag taacttaaag 240 ttaaaaatta acttattaaa ttaaaaatat tttaataaaa ttaactgtta aaataattga 300 aaagtataaa ataacaaaaa taataaatca taattaattt aaataagata actaggaaaa 360 taaataaaag attaaaaaaa taaaaaacta aagtttaaa taatgtttat aaaaagttaa 420 aaattattaa aaattattta taaaacagtt aaattataaa caaacttttc gcttatgaaa 480 aataaaagct tacctaactt tagtagacaa cttgtccaac aattagttga tacctattgc 540 ccttaaagta tcaattattg gttttgtcaa caagctatct tttaatctta atttatggt 600 aaaaaatccg tcgccttcaa gttacatcat ttaacacatc tgctcattag aaaaataaaaa 660 ttcttcctaa acgattagta gaaaaaatca tttaataat gaataagaaa gaaatatag 720 ggaaaaataa cttcatttaa aaaaacattt ggattatatt ttaccttaaa atatctaaat 780 atttttaaat gactaatttt ttatattttt atatacactg taactaaaag tatacaagtt 840 attatgttat gtatcataaa gaaatactta aaaaatctac tgaaaaatat cttacaaagt 900 aaaaataaaa taagaaataa gttagtggga taattatgat tttatttgaa aattgaaaaa 960 ataattatta aagaatttag tggagtaaga aagatttccg attattcttt ttttccataa 1020 taaaaaaaat ctagcatgac aacttttcca tagattttaa taatgttaaa tactagtagc 1080 agccgaccgt tcaggtaatg gaccttataa aatttcgaac gctccactcc acttgcaacg 1140 ggtgcgggcc ccaatttaat aacgccgtcg taacggataa agtccaacgt gaagcggtga 1200 aggtgcatct ctgactccgt caattacg aaccgctaa ttacgaagga ctccccgaaa 1260 atgataccga atatcatgt gtcatagca ccaagtgaca ccatacatta gcacgcgtca 1320 caatgatt ggagaacagt tccaccat atgcttaaa atgcccccac acccctcgtc 1380 catcttcgca gttcaatcc aatcaatta gttcattctc tttgcgcagt tcctaccctc 1440 tccattcaag gttcgtaaat ttttctgtt ttctgtttt tctttttc gttattgttt 1500 gttcttcatc agcatgatgt tgatttgat gtgttttaca tagtttcatc gatcttaat 1560 tttcataatc agaatcagct tttaatg cagaacgtt tttaatgt gattttaca 1620 tcgtatatta ggtctaatta gagtttttt ttcataaaaa atttcagatc cgtttacaac 1680 aagccttaat ttagattctg tagtagttggtttttttttttt atgaattact 1740 tcagatccgt taaagaacag ccttatttgt tgatacttca gtcgtttttc aagaaattgt 1800 tcagaccagt tgaaaaaagc ctgattcgtt gattctgtat agtttttcaa gagatattgc 1860 tcagatctgt tagcaactgc cttatctgtt gattctatgg ccatagatta ggggtttttt 1920 tttttctctc catgaaattg cttcttaaaa ctacgagatg gattttgatt ctgatttatc 1980 tgtgattgtt gattctacag 2000 <210> 3 <211> 2000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 3 aattaccctc gttgtcatac ctattttaga gccaatgcat aatgatatgg acacttgttt 60 atcaaggagt taattatttt ttcttttgtt tttcacttga aaaaaagatt gccatttgaa 120 ataggataac caattcttgt atttttgtat ttgacttata taactaaaaa aacaaaaatt 180 actcaaataa ttcaagtata aaattattta tataaatgat taaaaacatt gtttgggggt 240 gagaaattga tttaattaaa aaagagatta agttaacatg aaatagaatt aaattaaaaa 300 ctttatttta aataaaataa tgtttaaaaa tagaattaaa taagataact aagaaaataa 360 aaaaatta aaaaaaaaaaaaagtt taaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaahttttaa 420 aagggttaa aattatttta aaacttatttt aaaatagt taaataact ttcactaat 480 aaaaaaaya agcttaccta accttagtag acaacttgtc cacaattag atgatgccca 540 ttgcccttta agttttttt aacatcatt attgtttg tcacaagct atctttttgt 600 cttatttat tggtgaaaaa tccgtcgcct tcaagttgcg tcggttaaca catctcctca 660 tttagaaaat aaatttctc cctaaacgat tagtagaaaaatcatttta taataata 720 gaaaaaaaa taggaaaaaaacttca tcttaaaaa tatttagatt atattttact 780 ttaaaatac taaatttttt aaatgactaa ttttatatac actgtaacta gaaataca 840 agttattatc ttatagtct cataagaaa tacttaaaa atctagtgaa gatatctta 900 Caagdaaaaaaataag aaagaattta gtgggaattta tttgaaattt 960 gaaaaataat tattaaagaa tttagtggag tagaaagct ttccgatt tctttctttg 1020 tccataataa aaaaatctag catgacggct ttccataga ttttaataat gtaaaatact 1080 attagcagct gaccgttcag gtcatggaga cagtggggtc ctataaaact tagaacgctc 1140 cacatgcaac gggtgcgggc taaaattgtg acgtgggacc caatttagtt acgccgtcgt 1200 aacagataaa accaagtgtg aagcggtgaa ggtgcatctc tgactccgtc aaaattacga 1260 aaccgctaac tacgaagggc tcacccgaaa ttaggaaaat gcatccaata ccgaaatatc 1320 atgtgtgtca taagcaccaa gtgacaccat acatgcccac gcgtcacaat atgagtggag 1380 aacgattcca ccacatatgc tataaaatgc cccacaccct tcgtccttct tcgcagttca 1440 attccaatca aattagttca ttctcttttc gcatttccct acctacccct tcaaggttcg 1500 tcgatttttt ttttctttat tgtttgttct tcatcagcat gatgttgatt tgattgtgtt 1560 ttacatagtt tcatcgattc ttaattttca taatcagatt cagcttttat tattgcaaga 1620 acgtccttaa ttgatgattt tataatcgca aattaggtct aattagagtt ttttcattaa 1680 aaaattcaga tccgtttaca acaaccttaa tcgttgattc tgtagtcgta gattagggtt 1740 ttttcatgaa ctacttcaga tccgttaaac aacaccccta tttgttgata cttcagtcga 1800 tttttcaaga aattgttcag atccgttgat caaagccttt cgttggttct gtatagtttt 1860 ttaagagata ttgctcagat ccgttagcaa ctgctttatt tgttgatttt atggccatag 1920 attagttgtt ttcttcttca tgaaactgct taaaattgtg atggattttg attctgattt 1980 atctgtgatt gaccttacag 2000 <210> 4 <211> 2000 <212> DNA <213> Artificial sequence <220> <223> Synthetic polynucleotide <400> 4 attcattttt aatatgactt attgtcctaa aaaatttatt ttcgtaaatt aaataaaatg 60 aattttttct ttctttcaaa taatctaact agtcataatg agaatttgct aaaaaaaata 120 cataatgaga atcaatatta aatttattta tcaatataaa ttaatatcat tttatagaaa 180 aaataaaatt ttaaaattaa tcatatagaa ataatatttt tatattattg gttcaaatta 240 aaataatgtt aaaaaataaa atagattatt aattgatatt gatataaaat ttaaataaat 300 aatataatga ttgtttttta ttttattaat atgtaatcaa ctaattatta ttttttgaat 360 caattagtac ttaaagataa tattaattga tttttttatc cttttaggtg gcatgtgtgc 420 tgtgagacat tatcatcaat taatatgat atgatacata taatataga 480 daddy tgtagattgg aatgatta daddy daddy daddy 540 tatatatttg taatatattt ttcacatat atattttaaa actataagt attttttcat 600 gagacaatta ttgtcgaatt gataggttc attacttgtg agactcaatg agatttatat 660 ttgtattaa atttttaatt tgtgaatta aaatgataaaaatacatta aaaatcataa 720 taataaaa aacttatatt tataattg tgacagtaaa aaatctcttc ccattatact 780 taaaaaaa aaatttaata ataggccgc gccctagggt tttgagaaa aaatctcttc 840 ccacgcattc aactgcactg tacgtcgtcg ttttcacagc cgcataatag aagccgcgtt 900 ccccaaccct tcctcacaac attatcggac cctcccgcac cgtcaccaaa ataatatcc 960 acgcgctatt aggcgcgtga aactcactct aatccgaac cacgagacgt gagaagcacg 1020 agcttttagc gagcgtttca attgtcgcta cgaagcaga gaagataca aactgaacta 1080 gggtaatta gtaagggtat tttcgtaaac agaagaaag agttgtagct atataaac 1140 cctctaaccc tcgtcgcatt acttctcttc acacctttgt tcactcttct tctcttgcgg 1200 ctagggtttt agcgcagctt cttcttggtt cgtattcttc caccgtttta tggattttat 1260 tccttcgatt catgtttatt ctattggttt atgttgcttg caatttatat tttctgaatc 1320 tattgttgtt gttttcaatt ttatccatgt ttcatagatc aattttgtgt gtagtatgtg 1380 ctttttcttc ttctttttcg ttcgagttgt tgttaataac ggtgctaatt gtgttttcaa 1440 aagtgttttt tatttattta tttttgattt gatgtttttc attttggttt tgggctttta 1500 tgtgcttgtt atattcaaat ctttggatcc agatcttgta aaagtttttg gtttaagaaa 1560 gtttttggct actgttgaat agatctatta actgttactt taatcgattc aagctaaagt 1620 tttttggtta ctgatgaata gatctattaa ctgttacttt taatcgattc aagctcaagt 1680 tttttggtta ctgatgaata gatctatata cgtcacagtg tgctaaacat gcgttatgta 1740 tgggtgtgcc acaaatttta ctgtctattt atttatcttg tggaatcata ttgtgtttga 1800 tgcgttatga ttgagcatac ctatttttca gcttgttgga tgatgtgtat ctagataatc 1860 tgatattttt acggttctga aaggttttgt aaatggcaga ggccttaatg ttgttgaact 1920 tattttttta tttatgtggt gtgttgaact atgatggttt tgacaacttt ttctctggat 1980 tttttgcaga tttaaggaag 2000 <210> 5 <211> 2000 <212> DNA <213> Artificial sequence <220> <223> Composite <400> 5 agtttttttc tttcaaagaa tctaaatggt cataatgaga attctctaaaa aaaatacata 60 atgagaataa ttatggaatt tatttattaa taaaaattaa tagcattttg atagacaatt 120 aataaaattt taaaaataac catatagaaa taataatttt tttactatcg gttccaatta 180 aaataatgat aaaaaataaa atagattatt aattgatatt gatatgaaat ttaataaag 240 aatataatca tatattttat tgatatatga tatgatatag attaattgat attgattttg 300 atatggaatt taaaataat ataataattg tttttattta ttaatacgtg taatcaaata 360 attctcactt tttgaatcaa tcagtgtact taaagataat atcagttgaa tattttttat 420 ccttttacgt gtgctgtgag acattatcat caattgtgtt gtatatgata tatagatata 480 Gattattaa dattagatt gagtgatata fatherfather fatherfather fatherdadgt 540 father tttgcatat father father tgtaaaac tag tattcat 600 atattatta tcgagttgaa taagtctatt atttgtgaga gccaaccata tttatatatg 660 tgattaatt ttatctttgt gaattaaaaataaaaaattaccttaaa atcatataa 720 tagaaaact tattatta attaccatt attackttaaa aaaatttaat aattattata 780 atataata ctatcgagta atggccgcgc taggttttt gagaaaaaat cttcccacgc 840 actcaactgc actgtacggc gtcgttttca cagccgcata atagaagccg cgttccccaa 900 cccttcctca cacattctc ggaccctcca gcaccgtcac ccaacaat atccacgcgg 960 tagtaggcgc gtgaaacaaa ctctaatccg aactacgaga cgtgagaagc acgcgcttta 1020 gcgagcgtttt caatgtcgc tacgaaagca gagaaggata caacggaac taggtaat 1080 tagtaagggt atttcgtaa acagaagaa agagttgtag ctataataa accctctaac 1140 cctcgtcgca ttactctct tcacaccttt gttcactt cttctcttgc ggtagggtt 1200 ttagcgcagc ttcttctagg ttcgttatct accaccgttc tatggatttt attccttcta 1260 ttcgtgttta ttctattggt ttatgttgct tgcaatatgt tttttctgaa tctgtcgtcg 1320 ttgtcttcaa ttttatccat gtttcagaga tcaattttgt ttgtgtagta tgtgcttatt 1380 cttcttcttt tcgttcgagt tgttaataac ggtgctatgg tgttttcaaa agtgtttttt 1440 ttattacttt tgatttaaag tttttttggt aaggctttta tttgcttgtt atattcaaat 1500 ctttggatcc agatcttata taagtttttg gttcaagaaa gtttttggtt actgatgaat 1560 agatctatta actgttactt taatcgattc aagctaaagt tttttggtta ctgatgaata 1620 gatctattat ctgttacttt taatcggttc aagctcaagt tttttggtta ctgatgaata 1680 gatctatata cgtcacagtg tgctaaacat gcccttgttt tatctcgatc ttatgtatgg 1740 gagtgccata aattttgtta tgtctatttt tttatctgtt ggaatcatac tgagtttgat 1800 gcgttacgat tgagcatacc tatttttggg cttgttgtat ggtgggtatt tagatcttaa 1860 tctttttatg cttatgaaag gttttgtaat gacaaaggtc ttaatgttgt taaactttta 1920 tttttacttt atatggtgtg ttgatgtgtt atggttttga caactttttt tttttctgga 1980 tttttgcaga tttaaggaag 2000 <210> 6 <211> 2000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 6 attcattttt aatatgactt attgtcctaa aaaatttatt ttcgtaaatt aaataaaatg 60 aattttttct ttctttcaaa taatctaact agtcataatg agaatttgct aaaaaaaata 120 cataatgaga atcaatatta aatttattta tcaatataaa ttaatatcat tttatagaaa 180 aaataaaatt ttaaaattaa tcatatagaa ataatatttt tatattattg gttcaaatta 240 aaataatgtt aaaaaataaa atagattatt aattgatatt gatataaaat ttaaataaat 300 aatataatga ttgtttttta ttttattaat atgtaatcaa ctaattatta ttttttgaat 360 caattagtac ttaaagataa tattaattga tttttttatc cttttaggtg gcatgtgtgc 420 tgtgagacat tatcatcaat ttaatatgat atgatacata gatatagata taaatataga 480 tatataaata tgtagattgg aatgatataa tatattttaa atataaatta tatatatata 540 tatatatttg taatatattt tttcacatat atattttaaa aactataagt atttttcat 600 gagacaatta ttgtcgaatt gaataggttc attacttgtg agactcaatg agattatat 660 ttgtaattaa attttaaatt tgtgaaatta aaatgataaa aaatacatta aaaatcataa 720 taatataaaa aacttatatt tataatattg tgacagtaaa aaatctcttc ccattatact 780 taaaaataaa aaattaaata aataggccgc gccctagggt ttttgagaaa aaatctcttc 840 ccacgcattc aactgcactg tacgtcgtcg ttttcacagc cgcataatag aagccgcgtt 900 ccccaaccct tcctcacaac attatcggac cctcccgcac cgtcaccaaa ataaatatcc 960 acgcgctatt aggcgcgtga aactcactct aatccgaaac cacgagacgt gagaagcacg 1020 agcttttagc gagcgtttca attgtcgcta cgaaagcaga gaaagataca aactgaacta 1080 gggtaaatta gtaagggtat tttcgtaaac agaagaaaag agttgtagct ataaataaac 1140 cctctaccc tcgtcgcatt acttctctt acacctttgt tcactcttct tctcttgcgg 1200 ctagggtttt agcgcagctt cttcttggtt cgtattcttc caccgtttta tggattttat 1260 tccttcgatt catgtttatt ctattggttt atgttgcttg caatttatat tttctgaatc 1320 tattgttgtt gttttcaatt ttatccatgt ttcatagatc aattttgtgt gtagtatgtg 1380 ctttttcttc ttctttttcg ttcgagttgt tgttaataac ggtgctaatt gtgttttcaa 1440 aagtgttttt tatttattta tttttgattt gatgtttttc attttggttt tgggctttta 1500 tgtgcttgtt atattcaaat ctttggatcc agatcttgta aaagtttttg gtttaagaaa 1560 gtttttggct actgttgaat agatctatta actgttactt taatcgattc aagctaaagt 1620 tttttggtta ctgatgaata gatctattaa ctgttacttt taatcgattc aagctcaagt 1680 tttttggtta ctgatgaata gatctatata cgtcacagtg tgctaaacat gcgttatgta 1740 tgggtgtgcc acaaatttta ctgtctattt atttatcttg tggaatcata ttgtgtttga 1800 tgcgttatga ttgagcatac ctatttttca gcttgttgga tgatgtgtat ctagataatc 1860 tgatattttt acggttctga aaggttttgt aaatggcaga ggccttaatg ttgttgaact 1920 tattttttta tttatgtggt gtgttgaact atgatggttt tgacaacttt ttctctggat 1980 tttttgcaga tttaaggaag 2000 <210> 7 <211> 1614 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 7 tccaccctca caaaaaaggt tattgcctaa ttaatagtag ggattgaaga agtatcaata 60 atcaataaga gggacatttg gattgacaca aactattagt ataaaaaaaa aatgtaaaac 120 taaatggaca acaatctaag aaagcgagta tgtgttgtac tcggaaaaca taacataatg 180 tgattttgat tgtggaaact gaaaacaata acaattaagt tttatttatc tctttgccta 240 acaatttttt taattacttt ttttatagtt tttatgatga agataattaa tattttttac 300 aaatattata ttttcctttt taccatcttt gaagataatt gctttttttt ccaatttaga 360 caaatatttg agtatcaatg atattccttt ttaatccatt attgcaattt aaaagaccat 420 caatgattac attttcaatc aaatgacttt attagtcttc actttacatc gatttaaatc 480 aaactaataa ttttgtatgg actaaatctc tgaacatttt tatatttaca acatatttta 540 acatttatta aataattagt atttaatact attagtagaa taatgggagt agcaggaggg 600 aggcactgag agaatagaga tggcatggaa gtaagcaatc aagtcaaaat cagagttggc 660 caaccccaaa ggctgtagta ggtaagcatg gcccatttta gtttttacat tcatctctca 720 ttttcacctc aacggttcag attcaatctg actccccgat ctcagccgtg gattcaaatg 780 ccacctcagg cacatgcaat tccaaatgga tgaacctaac ccacaatcta atcttgttac 840 ttaggggctt ttccgtcatt aaatgacacc acctaccccc ttctccctat aaatggcaac 900 tcaatccccc ccttagaact cgcagcgctt gatttgaggc caggcaagcc ccactcaacc 960 accacacctc tcctcgttca cgctacccct ttctgctctt cttctacctt tcaaggtact 1020 cttctttccc tctgttgctg caaccttctc tttctttaag attgcctcaa tttcggatct 1080 tgcacctctg ggttgctttg ctttgctttt tcctctactg ggttgatttc tgtttcccta 1140 aaccggttta gacgaatgtg aacactactt cttttgttta attactctgg aatacgtgtt 1200 aggctttcag atctagttga aatcgtattg cacttttagg gggagtttgg atttctaata 1260 agaaattgac cttttgctga gaattggttc ggtgattaga gggtttccgt aaatttttga 1320 agttttacat gcttgtatct gtttattttt gtttctcaca tctattattg ttaggtgaag 1380 gaaattatgt attgagagtc tgtctgatac taaatataaa cacctcaata ggggctctaa 1440 cactgatttt atcatttgct gcttgtgtgt atggttaaag aaaggcaatt gtgttttaat 1500 tttctgcaag ctttcgtttg ctgaatttta tgcatatatt ttcctccctt ttgtgaactt 1560 cctttttgta gttctaattc catttttggt gtctgcagtt ttaaaagtat aaag 1614 <210> 8 <211> 1001 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 8 aatcgtgcgg gctggttcat caggggatgt tggttacaat aaatgttggt ttcttttctg 60 tactcttgtg tcttcttttc taggtagctt gtttttcgga caaagtttga agtctccacc 120 atcatctcgc aactgttgtt cccagaactg ggttcttgat cgacggtggc aaaattgctt 180 ttatttatct gtgttttaat gtgttgtgtt tgtcggaacc cctgattaca tttttgttaa 240 gcgcagcgag tttcaggact ttgctgcgtt gtgttgcttt ggtttattaa atgtcaactt 300 tctatttgta gtgttcaatt tttggcttgg tttgcttttt ctttataatt tgtgttcaaa 360 ttttggcttg gtttgcttt actataattt gtgttcaaat tttgggttgg attttttaac 420 gatcggctgt ttgctcttct tcctctgttt tgatgtgttc gtgactatgc aagaatcttc 480 aattttgcta aaataaactt gctttgacaa catagaatca aatccgagtg ctttaatatt 540 cggtggtttg ttttttttt tggttttatg aaagttaaaa ttttaaaagt aaatcgataa 600 ggtataattg tggttttat ttatcgagaa ttttttaagt gaatcgatat aatttatttc 660 ccctaaaata aaataccaaa gaatcgaatt cgaactttgt ctttaataaa actactaatt 720 taatcattat ttgttctgtg taagcatgag aaataaattc tacttatctt ttagtttaaa 780 accaaaacag gttaagaata attttctaa ggccgttatc aaggtcacca aaaatctatt 840 cgatctgacc atatattttc gatacttgta cgattcgcag atgttgattg gaaattgcaa 900 tgaataaatt acaaatgcca aatccgatta tgcaatgaat gaattacaag tgcatttatc 960 cgttttgaat ctgttcatgt ctaccaatgg gagagatttt t 1001 <210> 9 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 9 gctggagctg atttctgtgt gatgttggat gttcccaaac attttaagaa ctgtaatgtg 60 taatgggtct gtaatgacct ttgaaaataa gtttggtttg tgttgaactc tattgtcgca 120 ttaatgttac tactgtttgt tatcaatgtg tggaactgat atataattat caactctatg 180 ttggcctatt gtgttgaatt ttgttctcaa tccaatgaat tggcgtatat tagtgggttt 240 tttattcttc atgcttgtca cagatgaaaa acagggatga gttgtaagga tggtgaatca 300 tcccacgaat tagattttgg tattataatt taaagatatt attaggtagg aagaactctt 360 ggattagatt ctaaagtgat attatgaaaa cgcactaaag gattttgaac aaactgagat 420 catgatccct agtttcaatt aacttcccct tacctagatt ttatacatat gtaagctaga 480 gtgggaacat tattcagaat cggatccgtt taacagataa aaacaaaagc gatcgggtta 540 atcccatttt tacaaataac aacgcgggtt tatacatgaa acaaatgtca ttaccaagtg 600 atatttttct gctctatact ctatacccgt tttattatca ttaattttgt aattatatgg 660 attaatgaaa ggttcctccc agagtgaaat tgttgtgttg gcgtgcgtgt agagcttctc 720 ttccaacaag agacaagctt gagatcgtgg agtaacctgt cccttaacgt gctctttgtt 780 atacatttca cgtgtttgca gtttgcccgg ggatcatgga atgctggcag aagttggggt 840 tgagtagcaa agttgataat ttaattatgc aggtgcagtc ttttgctgaa ttattcttca 900 aactcatgct ttctattgaa tcttatcaaa caatgtagag tagctatgac tctgtggaga 960 gtgcttggag atgtcacaat gatgctgttt ggaagggact 1000 <210> 10 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 10 atcgtgcggg ctggttcatc aggggatgtt ggttacaata aatgttggtt tattttctat 60 agtctcgtgt cttcttttct aggtagcttg tttttcggac aaagtttgaa gtctccacca 120 tcatctcgca actgttgttc tcagaactgg gttcttgatc gacggtggca agattgcttt 180 240. tattaatctg tgttttaatg tgtttgtgtt tgtgagaacc cctgattaca tttttattaa gcgcagcgag ttttaggact ttgctgcgtt gttgctttgc ttttataaat gtcaactttc 300 tatttgtgtt caattttggc ttggatttgc tttttacttt ataatttgtg ttcaaatttt ggcttggatt ttttaactat cggctgttgc ttttcttctt atgttttgat gtgttcgtga 420 ctatgcaaga atcttcaatt ttgctaaaat aaacgtgctt tgacaacata gaatgaatt cgagtgcaca attcggtata attgagaaat tatattgtg gtttttattt attttgagtt ttttaattga acatttccac taaataaaa tgccgcctaa gattgaat tgaacttttg tttttaataa aactactaat ttagtcataa tttcttctgt gtaaccatga gaataaatt atactgatct tttagtgaaa aaccaacaag gctaagaatg atttttctaa agcctttag ttagaggcca ctaaaatcta tacgatctgc ccatatattt tcgatacttg aacgattgca gatgttgatt agaagttgca atgaataat tataagtgcc caatccgatt ttcaccaaaa tctatacgat ctgcccacat attttcgat cttgaacgat tgcagatgtt gattagaaat tgcaatgaat aaattacaag tgccaaatcc gattttgcaa tgaatgaatt acaagtgcat 960 ttatccgttt taaatctatc catgtctacc aatgggacca 1000 <210> 11 <211> 1001 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 11 attcaatcaa accgttcatg cttaatcaag ttgggaacaa caaaaaaaat caaaacaatg 60 tttctgggtt tcggtttcat ttcatcaaga tgatctgttt atcttttttt ttttaatttt 120 aatttaaagt ctttgtattt tgtatgtaaa gatgtaaaat tatgattatt aggtggtgca 180 tgtgttgcgt catgggccaa tgttatcctc tgcttttaag ttggaagagg cccagctcac 240 gtgtgatgta cggctgtgat tgtgtaattt gcaaaatcaa aaataacccc cgagtcatat 300 atgcatcttt ttattttatt ttattttatc ttattattga catatttaga caccttttaa 360 aattatgatg atcatctcta aagcaaggta tgaccataat ttttccaaat tgctttttat 420 aactgatttt ggttcatctc ttagaattga ttttggttca gattccaaac atcctttata 480 ttgctactat tttatttttc ttttgacccc ccctatgtct tctctctaat atttgtcctc 540 ttccccgaag catatgccaa ggttgggttt ctttatccac gcctgtgccc gttatcactt 600 gctatggata attgaaatcc gtggacagtg aggagtgggg ttggtttaag gtgggtgggt 660 ggatgatgtc tattgcttaa atatgggacc acttttcttc ctcaataatg catatattct 720 agtgttgtcc atttaataat gattcgtgat catagccttg ggaaaaaaat gtacactatt 780 ttttatattt tatgccaaaa tttggacaag cttgatctta tcagcttcag cggggaatgc 840 cacttccttc tagttacttc catggaatcc ttcgcggaaa agacgtggca cttgtgagat 900 gagtaactga gaagaaagca ttagtaattt gacacgtata aatcgttgac tcattcttgt 960 gatttagcat ttgcctatta tttttatcaa atgccaacta g 1001 <210> 12 <211> 600 <212> DNA <213> Artificial Sequence <220> <223> Synthetic polynucleotide <400> 12 ttcaatcaaa cggttcatga gtaatcaagt tgggacaaca acaaaaaaaa tcaagccaat 60 gtttgtgggt tttggtttca tttcattaag atgatctgtt tatctcttct tttttttttc 120 tttttttaaa tttaaagtct ttgtgatttt gtatgtaaag atgtaaaatt atgattatta 180 ggtggtgcat gtgttgcgtc atgggccaat gttatcctct gcttttaagt tggaagaggc 240 ccagcttatg tgtaatgtac ggctgtgatt gtgtaattta atttgcaaaa tcaaaaataa 300 caccagaggc atctctttat tttctctgga ccccaccatg tcttctatgt aatatttgtt 360 gtcctcttcc ccgaagtata tgccaaggtt gggtttcttt atccacgcct gtgcccgtta 420 tcacttgcta tggataattg aaatccggtg agagttagga gtggggttgc gtgggtgggt 480 gggtgggtga tgtctcttgc ttaatatggg accacttttc ttcgtcaata atgcacatat 540 tctagggttg tccatttaat aatgatttgt gatcatagcc ttggggaaaa accgtacact 600 <210> 13 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 13 ttcaatcaaa cggttcatgc ttaatcaagt tgggaacaac aaaaaatcaa aacaaagttt 60 gtgggtttcg gtttcatttc atcaagatga tctgtttatc tttttttttt tttttaattt 120 aaagtctttg tattttgtat ttaaagatgt aaaattatga ttattaggtg gtgcatgtgt 180 cgcgtcatgg gccaatgtta tcctctgctt ttaagttgga agaggcccag ctcatctgtg 240 atgtacggct gtgattgtgt aatttgcaaa atcaaaaata acccccgagt catatatgct 300 tctttttatt ttatcttatt attaacatat ttagatacct tttaaaatta tgataattat 360 ctctaaaaca aggtctgacc ataatttttc caaattgctt tacatttttt agtgatttta 420 tagctgattt tggttcatct cttagaattg atttcggttc agctcacggt ctttccaaac 480 atactatata ttgctactac tttattttct ctagaccccc ctatgtcttc tctctaatat 540 ttgtccctct ccccgaagta tatgccaagg ttgggtttct ttatccactc ctgtgcccgt 600 tattactttg ctatggataa ttgaaatcag gggagagtga ggagtggggt tggtttaagg 660 tgggtgagtg ggtggatgat gtctattgct taaatatggg accactttc ttcctcaata 720 atgcacgtat tctagtgttg tccatttaat aatgattcgt gatcatagcc ttgggaaaaa 780 aacgtacaat attttttata ttttgtgcta aaatttggac aagcttgatc ttatcagctt 840 cggcggggaa tgcctcttcc ttctagttac ttccatggaa tccttcacgg aaaagacgtg 900 gcacttgtgg gatgggtaac tgagtagaaa tcatcagtaa ttttgacacg tataaattgt 960 tgactcaatc ttgtgattta gcatttgctt tttattttta 1000 <210> 14 <211> 999 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 14 gctggagctg atttctgtgt gatgttggat gttcccaaac attttaggaa ctgtaatgtg 60 taatgggtct gtaatgacct ttgaaaataa gtttggtttg tgttgaactc tattgtccca 120 tcaatgttac tactgcttgt tatcaatgtg tggaattgat atataattat caactctatg 180 ttggcctgtg gtgttgaatt ttgttctcaa tccagtgaat tggcgatccg tttaacagat 240 aaaaacaaaa gcgatcgggt taatcccatt tttacagata acaacgcagg tttatacatg 300 aaacaaatgt cattaccaat tgatattttt ctgctctata ctctataccc tttttattat 360 cattaatttt gtaattatat ggattaataa aaggttcctc ccagagttaa attgttgtgc 420 gagggtggca ttgaaaatac atttcacgtg tttgcagttt accgaggatc atggaatgct 480 agcagaagtt ggggttgagt agcaaagttg ataatttaat tatatgcagg tgcagtcttt 540 tgctgaattc ttcttcaaac tcatgctttc tattgaattt tatcaacaat gtggagtgct 600 atgacctgtg gagagtgctt ggagatgtca caatgatgct gtttgggaag ggactatcac 660 ggattccgcc atcgtgatca acagagttga catgttttat caaaattggg ttcgtgcaca 720 acaatcaaat aaatttagac aggttgcaga attaatggag gtgaatgatt cttggagtcc 780 gtcgactttg gaaggttaaa atgtaacctt gatgcatctc tcaaccatgt tcaaaactgc 840 acagcttttg gtttatgcgt tcgggcatct tattgttgcc agaactgatg ttgtgaaacc 900 atgcatgcct gttatggagg gtgaggcgtt agggttgcag ttggcgattc agtttgttct 960 atatgcggga atgcaaaatg tggactttga aacagattg 999 <210> 15 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 15 atcgtgcggg ctggttcatc aggggatgtt ggttacaata aatgttggtt tattttctat 60 agtcttgtgt cttcttttct aggtagcttg tttttcggac aaagtttgaa gtctccacca 120 tcatctcgca actgttgttc tcagaactgg gttcttgatc gacggtggca agattgcttt 180 tattaatctg tgttttaatg tgtttgtgtt tgtgagaacc cctgattaca tttttattaa 240 acgcagcgag ttttaggact ttgctgcgtt gttgctttgc ttttttaaat gtcaactttc 300 tatttgtgtt caattttggc ttggatttgc ttttacttta taatttgtgt tcaaattttg 360 gcttggattt tttaactatc ggctgttgct tttcttccta tgttttgatg tgttcgtgac 420 tatgcaagaa tcttcaattt tgctaaagta aacgtgcttg gacaacatag aatgatattc 480 gagtgcacaa ttcgttataa ttgagaagtt ataattgtgg tttttattta ttttgtgagt 540 tttttaattg aacatttcca ctaaaataaa atgccgtcta agaattgaat tctaactttt 600 gttttaataa aactactaat ttagtcataa tttcttctgt gtaagcatga gaaataaatt 660 atactgatct tttagggata aaccaacaag gctaagaatg agttttctaa ggcctgtaga 720 ggccaccaaa atctatacga tctgcccata tattttcgat agttgaacta ttccagatat 780 tgattggaaa ttgcaatgaa taaattacaa gtgcctaatc cgattttgca atgaatgaat 840 tacaagtgca tttatccgtt ttaaatcaat ccatgtctac caatgggacc agtaaaagcc 900 caagcagata tcatagtgca tggtgcatac accaaacggt ttatagccag tcccgaagct 960 caggctttta catatatcgt tgcagcctat tgttagaaga 1000 <210> 16 <211> 999 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 16 gctggagctg atttctgtgt gatgttggat gttcccaaac attttgagaa ctgtaatgtc 60 taatgggtct gtaatgacct ttgaaaataa gtttggtttg tgttgaactc tattgtccca 120 tcaatgttac tactgtttgt tatcactgtg tggaattgat atataattat caactctatg 180 ttggcatgtt gtgttgaatt ttgttctcaa tccagtgaat tggcgtatat tagtgggttt 240 tttattcttc atgtttgtca cggaggaaaa acagggatga gttgtaagga tggtgatcat 300 tccacgaatt agattttggt atggtaggtt aaagatatta ttaggtaggg agaacttttg 360 gattagattc taaagtgata ttatgtaaac gcactaaagg attttgaaca aacagatcat 420 gacccctagt ttcaattagc tgcccattac ctagatttta tacatatgta tgctagagtt 480 ggaacattag tcagaatcgg atccgtttaa cagataaaaa caaaagcgat cgggttaatc 540 ccatttttac agataacaac gcaggtttat acatgaaaca aatgtcatta ccaattgata 600 tttttctgct ctatactcta tacccttttt attatcatta attttgtaat tatatggatt 660 aataaaaggt tcctcccaga gttaaattgt tgtgttgggg tgcgtgtaga gcttgagatc 720 gtggtacctg tcccttaacg tgctctttgt gcgagggtgg cattgaaaat acatttcacg 780 tgtttgcagt ttaccgagga tcatggaatg ctggcggaag ttggggttga gtagcaaagt 840 tgataattta attatgcagg tgcagtcttt tgctgaattc ttcttcaaac tcatgcattc 900 tattgaattt tatcaacaat gtagagtagc tatgacctgt ggagagtgct tggagatgtc 960 acaatgatgc tgtttgggaa gggactatca cggattccg 999 <210> 17 <211> 999 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 17 gctggagctg atttctgtgt gatgttggat gttcccaaac attttaagaa ctgtaatatg 60 ggtctgtaat gacctttgaa aataagtttg gtttgttttg aactctattg tcccatcaat 120 gttactactg tttgttatca atgtgtggaa ctgatatata attatcaact ctatgttggc 180 ctattgtgtt gaattttgtt ctgaattggc gtatattagt ggatttttta ttcttcaagc 240 ttgtcacgga ggaaaaacag ggatgagttg taaggatggt gatcatccca cgaattagat 300 tttggtatag taggttaaag atattattag gtagggagaa cttttggatt agattctaaa 360 gtgatattat ggaaacgcat taaaggattt tgaacaaatt gagatcatga tccctagttt 420 caattagctg cccattacct agattttata catatgtaag ctatctgcta gagttggaac 480 attcatcaga atcggatccg tttaacagat aaaaacaaaa gcgattgggt taatcccatt 540 tttacagata acaacgcagg tttatacatg aaacaaatgt cattaccaag tgatattttt 600 ctgctctata ctctataccc tttttattat cattaatttt gtaattatat ggattaatta 660 aaggttcctc ccagagttaa attgttgtgt tggggtgcgt gtagagcttc tcttccaaca 720 agagacaagc ttgagatcac ggagtaacct gtcccttaac gtgctctttg tgcaagggtg 780 gcattgaaaa tacatttcac gtgtttgcag tttacccgag gatcatggaa tgctggcaga 840 agttggggtt gagtagcaaa gttgataatt taattatgca ggtgcagtct tttgctgaat 900 tcttcttcaa actcatgctt cctattgaat cttatcaaca atgtagagta gctatgacct 960 gtggagagtg cttggagatg tcacaatgat gctgtttgg 999 <210> 18 <211> 1000 <212> DNA <213> Artificial sequence <220> <223> Synthetic polynucleotide <400> 18 ggccattcat tccacaccgc tctgtgctga gagttttttg agcgttgccc ttataatatg 60 tctaatatat ccataatttt tccacgtctc ttactctgtg tgtgtgtttc tctcctcttc 120 ctcctatttt gttattgta tgttctttg taattttta catgatcaac taaaaacatg 180 tactctctgt ttgtatgccc tacccatg tctcttaata tcaataaa gaagagtgtt 240 caagttaatg tttggattcc aatgctctc tcgatgaact cgcgtgcatt ttttaata 300 cttattgttt ctccaattc cgaaaagttc gagctgcaaa tttggacaga tgataaatgg 360 taggcaagtg tggtgttgtt tacataaaa ctgctaaaac taaggtgtta atattactg 420 gtcatgtaag atattgtttt ctaagtttat atttagtagt aaataatagt tacactatta 480 aaaaagtaa aaccttttaa aaaaaataaaagtaaaat catatttgt cacgtctttc 540 agaaacaaag ctactgacat ttttacttg ctaattattg tagtatcatg ttattgttgg 600 ttttcgttta cttcccgtct tcatcaccat tggtattgag aaaacaagtt tgaacaatgt 660 gcacatttcg agaacaacga ccacttgatt aagtactagg tcaatttca gggagtaata 720 atttattatt tctcatttta ttttatgattttttgt ccgaaaaata ggaaatcttc 780 tctaaaattt attaatctat tgattgtag accatcgtgc tgctatggcc cctaatatat 840 aaaatgtgac ttctgaagtg gtatgatggt tttttttttt cttgtttatg taagacaagg 900 ttcggacaga tgcagatttt acattaacaa taatcctctg tttgtttgta gacttgtagt 960 ggaaaaaaaa atgaacaaat aagattcaat attgtatttt 1000 <210> 19 <211> 1001 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 19 gggcttgatg tcgttgatta gggtttatga ttatgctcag taattttagt tgtgtttgag 60 tttgagtatc tttatggttt tgtgtcaccg tggttcttgt ttttgaccaa tatatctggt 120 tgtttatagt cgatttaatg aaatgataat cagaaattgg agtatcgaag ttctaatgat 180 ttttactatt tgtgcgctgg atgtggaaaa tcttctgttt cacgaatgcg tgtcttgtta 240 ttcttcttca gaacacaaca ggctaagcag ccttcaaaac aataaaggaa cttaattaac 300 aaaacctcga cggaaattta cctacagttt ttgcctgtga aagataaaac cacaattttc 360 acgcccaatg ttctcaaagg attggggtct caagtgtgca gattggtgag aaaaatagat 420 acaacgagca ttttttgttc tgagaacatg aaatggtatt catcctttaa gtccgtgtgt 480 gtgtttatct ctgttcagac agtcagacct atgaattcat gaaacatgtc cagaaacatg 540 tccatcctct tgacttggtt ttaatttgat ggaaagcctg ctgatatcga gatgaacatt 600 attaaaagtc caattgtttc tacagaacta attgcaatcc tacgagatcg caagcaccat 660 gtcatggctt actatattat ttgaagaaaa aaaatcatag gctcagtgct tttcgacaaa 720 tagagcattg ttgattgtta agtcaatcgt gttttgggta tagggtggtc tcataacatt 780 tgtaggcagg attattctag caaattttca aagtacttta taatccgaat tttgcctgat 840 tgctttgttg ttccacagaa gatacacata attgtatttc catgaactcc taaatagttc 900 tcaaggtagg caaggtaaaa gcgataccat ttttgattga tatccctatc aaaaacttta 960 tttcttattt taaagggaat tctttataac taatgatttg c 1001 <210> 20 <211> 1001 <212> DNA <213> Artificial Sequence <220> <223> Synthetic polynucleotide <400> 20 gagggggga aatgaaaaaata aaaaaaaaaa aattgtgtat tattgaattt ctctggaatc 60 ttcttctgtg tatggttttc cttccttgtg ttttcttcct aattcacttt cgagggttgt 120 acttgttcct ttcgtcttaa atccttggat ggttgatgat catgaagttc tctttaaagt 180 taaattatta tcattttgtg catgctctct ctctctcact tggtccacaa caattgaatt 240 gaatgtagta tcattattcg ggtctggttg gttgtaccat ttcactagta cttcttactt 300 tttcctgcat cctctctcga ttagaattaa aatatttctt tcttttctga agtttatgaa 360 tgattatact tgtgattttt gtgaccagtg tgttcatagc atattggtta aatatttatt 420 aaaaatcata atcaatataa tttcatgcat gtcaataaaa tttttaattc cttaatcaat 480 attttaaaaa tattagttag catttaacca aagaataaaa tatattaaaaa gtataaaacg 540 gttaatcttg ctatgcgaca aaatgtccta attatagaat cgctcgagca catgctacga 600 gtgggtccac cagtgtggat gggtaattgt aattcacttc cctaatgaag acaaattaaa 660 tgcgaggaag aatgaatgta gaacgttgat agagaatgga ctgaacaaga ttgaagcata 720 tcatatagct atgcacctct tattggttgt atttctgtgc taattaaatt acaaacaagt 780 gaacacgtgt ttgagagtaa ctagtatgtg tgttcaagtt cgggaatgca tcctttagag 840 gtttcaattc gaaacattga atatataata atataagaat tggatagacg caagattttt 900 atatgataac attaagtgaa aactgtatgt atgacaatat gatattcatt tagattcaaa 960 ttatcactgt actgctttat ttccccctgt atcattgcca a 1001 <210> 21 <211> 1000 <212> DNA <213> Artificial sequence <220> <223> Synthetic polynucleotide <400> 21 gccgcagcgc gacgtggagg aaatgcgcga tggtaggggt tgggtggttg gttgcgtggt 60 ggtcggggct atggtggtga tggcacgcgc gatggtgaga gggtgatgtt tggttgtggg 120 tttttgacct cacggccccc ttcgatcgcc aacttagcga tgccttcaag gtccttgact 180 actccaccga ctatgtcgtc gtctccgagc tctgccacat cctctccgag cttctgtcaa 240 ttctaagttt ttaccaaatc tgagttgcga tttctgtgat gcatgttgtg ttttttctca 300 tctaatctt aacatctggt tcttatgttt tgtcgttcct tcaatgatt gtgtttttta 360 ttttgattt tggggtgta gttgaatggc attcgatga gatgaaaagg tggggaaga 420 ggaataaaaa ttgtggcga ctttttatat tttgtgataa tttttaatct ttaaattatt 480 tttaaaaaat tatattaaa aaacaatct tttatttg tgataaaaat aacatatttt 540 gaatttatt aaatattaatattaattatta aaatattatta atactagtat ataatggga 600 gtagtaggag ggaggcagtg gattgagttg agagtcataa ataacaggt ggcaagaga 660 gaacagagat ggcatgcaag tatgcaat ttgcaatca gtcaaatga gagttggcca 720 acccaaagg ctgtagtagg taagcatgc ccatttagt ttttacactc accctcatt 780 ttcacctcaa ccactctgc ctccttcac atccactca cggttcagat tcaatctgac 840 tcccaatct cagccgtgga ttcaatgcc acccaggca catgcaatctg cattgcaaa 900 tggatgaaca taacccacaa tctaatcttg ttacttaggg gctttccgt cattaatga 960 caccacccac ccccttttcc ctataaatgg cactcagtg 1000 <210> 22 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 22 ttcaatcaaa cggttcatgc ttaatcaagt tgggaacaac aaaaaagtca aaacaatgtt 60 tgtgggtttc ggtttcattt catcaagatg atctgtttat ctttcttttt ttaaatttta 120 atttaaagtc tttgtatttt gtatgtaaag atgtaaaatt atgattatta ggtggtgcat 180 gtgtcgcgtc atgggccaat gttatcctca gcttttaagt tggaagaggc ccaactcatg 240 tgtgatgtac ggctgtgatt gtgtaatttg caaaatcaaa aataaccccc gagtcatata 300 tgcatctttt tattttatct tattattaac atatatatat atatatatta atacctttta 360 aaattatgat gattatctct aaaacaaggt ctgaccataa tttttccaaa ttgctttacc 420 tttattagtg attttatagc tgattttggt tcatctctta gaattgattt tggttcagct 480 cacggtaatt ccaaacatcc tatatattgc tactacttta ttttctctag acccccctat 540 atgtcttctc tctaagattt gtcctcttca tcgaagtata tgccaaggtt gggtttcttt 600 atccattcct gtcagtcctg tgcccgttat cacttgctat ggatgattga aatccgggga 660 gagtgaggag tggggttggt ttagggtggg tgggtgggtg gatgatgtct attgcttaaa 720 tatgggacca cttttcttcc tcaataatgc acatattcta gtgttgtcca tttaataatg 780 attcgtgatc atagccttgg gaaaaaaacg tacactattt tttatatttt gtgctaaaat 840 ttggacaagc ttgatcttat cagcttcggc ggggaatgcc acttccttct agttacttcc 900 atggaatcct tcacggaaaa gacgtgggtg gcacttgtgg gatgggtaac tgagtagaaa 960 acattagtaa tttgacacgt ataaatcgtt gactcattct 1000 <210> 23 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic polynucleotide <400> 23 atcgtgcgga ttggttcatc aggggatgtc ctttcttgtg gttacattaa atgttggttt 60 cttgctcttg tgtcttcgtt tctaggtagc ttgtttttcg gacatagttt gaagtctcca 120 ccatcatctc gcaacttttg ttcccagaat tgggttcttg atcgacggtg gcaagacttc 180 ttttattatt ctgtgttttt gtgtttgtga gaacccctgc ccctgattac atttttgtta 240 agcgcagcga gttttaggac ttttgctgtt gcgttgttgg tttgtttttt aaatttaac 300 tttatattg tgttcaattt tggcttggtt tgcttttaca atatcaactt tatactttgg 360 tgtcaaattt tggctttgga tattttaact aacggctgtt gttttttctt cccatgttat 420 gatttgtctg ccgggaagat gcaagaatct taaatctttt actaaaagta aacgtgcttt 480 gacgacgggg aaccatattc gagtccttga tatttggtag tttgttttta tttttagttt 540 gaagaatata atttgttgac attttataat tgattgagaa ggtataattt gtattttata 600 ctatcgggat tttctttaa ttgaatggag ttttttcaaa aatggatgat atataggaat 660 tgaatttgaa tttgtatcat agggcatagt gatgtgatta taattatatt ttcttggtgg 720 ttaatcgttt tcttaggatg aaaacatttt ttttttcttt gatgtgttgc attatcttaa 780 atgaatttct tgtttctaga taaatcttaa aatgaattttt aactgtggta catcaacatg 840 taattgacat aacgcgtaaa cttagaaagt ttgtaggttt caacaagata tgaagaatga 900 aacaaactag aataaggatt ctatttttat acaattaatt aaaattctcc cctagatctt 960 tcgaatagaa atgtttaata ttctctcctt ttctataaaa 1000 <210> 24 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 24 atcgtgcggg catcagggga tgtcgtttct tatggttacg ttaaatgttg gtttcttgct 60 attgtgtctt cgtttctagg tagcttgttt ttcggacata gtttgaagtc tccaccatca 120 tctcgcaact tttgttccca gaattgggtt cttgatcgac ggtggcaaga ctccttttat 180 tattctgtgt tttaatgtgt ttttgtgttt gtgagaaccc ctgcccctga ttacattttt 240 gtaagcgcag cgagttttag gacttttgct tgttgcgttg ttgatttgct ttttaaattg 300 taactttata tttgtgttca attttggctt ggtttgcttt taaaaatatt aactttataa 360 tttggtatca aattttggct ttggatattt taactatcgg ctgttgcttt ttattcccat 420 gttatgattt gtctgcggga acatgcaaga atcttaaatc ttactaaaag taaacgtgct 480 ttgacgtttg aagaaaataa tttgttgacg ttttataatt gactgagaag gtataatttg 540 tgttttatac tatcgggatt ttctttcaat tgaatggaga tttttttctt tcaaaaatgg 600 atgatatata agaagaattg attttggact tttatttatt actaattttg ataaaactac 660 ttttattctt taaagcatat gttaaaatta attttaatca tgtatttcag tgtaagcatg 720 ggaagagtaa gtttgatggt ttagtgaaaa ccaggctaag aataatataa tcccctttta 780 aattagacct tttttttatt aaggccacca gaatctatac tccgccgatt acaaatgcca 840 aatccgatat ttaaccgttt tgaatttgta tcatagtgca tagtgatgtg attataatta 900 tattttcttg gtggttaatc gttttcttag gatgaaaaca ttttttttct ttgatgtgtt 960 gcattatctt aaatgaattt tttttttata gataaatctt 1000 <210> 25 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 25 aatgattata gaaaatagta tgctttctgg tgggagcagc actccttaag ccttagttac 60 tcatatggaa aatatcctag tttgtgggat ggtcaacttg ggtagttatg gtcccaaact 120 ctcaatttc caagttgtgg cataaattct attgcacctt ttaacaagct ttgcttgttc 180 cagtgtgttt tattatgatt tgtgattat acaaccttgc gtttgagtgc cattttagtc 240 gtcttatccc ttactagttg aatttgtaac tgttatgtgt tatcagacaa aaattggggg 300 ttcttcactt attgacactc gtcatccact aatgttttgt gactgtgact tcttctggcc 360 gatatatgct ttcttttgta tgggcataca aaggcctctt gttcatgcta tattcctttt 420 ttgttctatg gtttgtggtg gaatgaattt tattcaactg gttggttgtt cttgaaacca 480 gagtgtactt cattcgtagc aatagcatct aagcggttaa tggtcatgct ttatgatact 540 agtagcactt gtgcagttta ttgctcttt ggccaatatg cacttgtgga aaaatgcttt 600 ttcagatatt gatccatact tcttaacatt tcgttttgga gtgtaggtag ttggaaagat 660 gggaaaaagg agagaaaatg acagatatgg taaataaatt atttaaatac atttttggtc 720 tatataattt agtatttttt aaatttgtt tttggaagaa aaaatagt tcttgtaaaa 780 taggattgtt ttattttttg tttttaaatt gttttagata agatttgttt tcctgcctaa 840 agtatttttt attgtttaaa ctttaaagag ttatctaaaa tacttaaagg ataaaaaaaa 900 tcaatacatt ttatatgaat taaaaaaaat acaggacaaa aataaaataa aaaattataa 960 ggatcaaaat tatatttaga cccaaataaa gtgataggaa 1000 <210> 26 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 26 atcgtgtggg ttggttcatc aggggatgtc gtttcttatg gttacgttaa atgttggttt 60 cttgctattg ggtcttcgtt tctaggtagc ttgtttttcg gacatagttt taagtctcca 120 ccatcatctc gcaacttttg ttcccagaat tgggttcttg atcgacggtg gcaagactcc 180 ttttattatt ctgtgtttta atgtgttttt gtgtttgtga gaaccccctg cccctgatta 240 catttttgta agcgcagcga gttttaggac ttttgctgtt gcgttgttga tttgcttttt 300 aaattttaac tttatatttg tgttcaattt tggcttggtt tgcttttaaa atattaactt 360 tgtaatttgg tatcaaattt tggctttgga tattttaact atcggctgtt gctttttctt 420 cccatgttat gatttgtctg cgggaagatg caagaatctt aaatcttact aaaagtaaac 480 gtgctttgac gtttgaagaa aataatttgt tgacatttta taattgactg agaaggtata 540 atttgtgttt tatactatat tatcgggatt ttcttttaat tgaatggaga ttttgttttt 600 tcaaaaatag atgatatata agaagaatgg aatttggact ttaattataa ctaattttga 660 taaaactact tttattcttt aaagcatatg ttaaaattaa ttttaatcat gtatttctgt 720 gtaagcatgg gaagagtaag tttgatggtt tagtgaaaac caggctaaga atattataat 780 ccccttttaa attagacctt ttttattaag gccaccagaa tctatactcc gctgattaca 840 aatgccaaat ccgatattta accgttttga atttgtatca tagtgcatag tgatgtgatt 900 ataattatat tttcttggtg gttaatcgtt ttcttaggat gaaaacattt tttttctttt 960 atgtgttgca ttatcttaaa tgaatttctt ttttatagat 1000 <210> 27 <211> 1001 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 27 aatttcctc cccttgtcta tgatcgagga agaaaatctg tatatatta tgcaaaaaat 60 aattaaggtc ttttccttta aatgggctgg ttcaatgaac cgagaccact gcaggttcat 120 ggggatggga ggattaagag gctatgtttt ttaatcttcc gatgttactg ttgttttttt 180 tttaatttca ataaggatat tatatatgta gtactatgca agtagcttag agttgggtag 240 aagggcatgt tcatggtgtt aattatgtta tgtatgcgtg tgagtgctgt tatgatggca 300 gtgacaatgc ttatgatatt catactcata aagctaggtt gttctttcta aataaataaa 360 tcatggccca tgggcattat acactgttaa cactcgtatt agcataggcc cgaggataga 420 gacttgagga aacaagtttt aagtatccaa ctagtaacaa atgaataatc ttttaaatta 480 atgttatttt attttaagtg tgggttggca aacagattaa gcaaacaata tgtataattg 540 cggactaaaa taattgccga tagatactag tataggtggg ccaaaaagaa ggatgaagta 600 aacaaaagag gtccgttgat gtgggccaaa ccaatttcac atttgaaaga taagaaaaaa 660 cttttgtaca cgcggaactt tgcactggat taggtgcagt gcagtactaa ctgttttcat 720 cgaaaatgac cattagcaat aacctgcaag ggagaaaatg ccaaaatgaa atcacgttgg 780 atcagctggt gctgtcctag ctattattcc tatgtttctg cacggaaaac taccgtttgt 840 attcgaatga gcaatgagaa atgacaaaga gcctatctct agattctttt cttgttggtg 900 attcttgata agtttatttt gtaaatagcg ctgcaagagt atgaagccta gccaaatatg 960 atcatatata tattgtcaat attatgtttc tcaaaaaata g 1001 <210> 28 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 28 gtaattcatt ccactgctct gtgctgggag ttttttgagc gttgccctta taatatgtct 60 aatatccata aatttccacg tctcctactc tgtgtgtgtt tctctcctct tcctcctatt 120 ttgttatttg tatgttcttt tgtaattttt tacatgatca actaaaaaca tgtactctct 180 gtttgtatgc cctaccaatg tgtctcttaa tatcaatatc aaaaagagag tgttcaagtt 240 aatgtttgga ttccaatgct tctctcgatg aactcgcgtg catttttta aaatacttag 300 tttctcccaa ttccgaaaag ttcgagctgc aaatttggac agatgataaa tggtaggcac 360 gtgtggtgtt gtatacataa aaactgctat aactaaggtg ttaaatatta ctggtcatgt 420 aagatattgt tttctaagtt tatatttagt tgtaataat agttaacacta ttaaacaaag 480 taaaacattt aaaaaaaaca aacaaagtaa aacattttaa aaaaacaaac aaagtaaatc 540 atattttgtc acgtctttca gaaacaaagc tactgacatt ttttacttgc taattatgt 600 agtatcatgt tattgttggt tttcgtttac ttcccgtctc catcaccatt ggtattgaga 660 aaacaagttt ggacaatgtg cacatttcga gaactacgac aacttgatta agtactgtgt 720 caaatttcag ggagtaataa tttattattt ctcatttaat tttatgattt atttttgtc 780 cgaaaaatag gaagtcttct ctaaaattta ttaatctatt gattggtaga ccattgtgct 840 gctatggccc ctaataataaa tgtgccttct aaagtggtat gatggtttct tttttcttgt 900 ttatgtaaga caaggatcgg acagatgtag attttacatt aacaataatc ctctgtctgt 960 ttgtagtgaa taaaaaaaaa aacaaatgaa caaataagat 1000 <210> 29 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 29 ggcttgattt cgttgattag ggtttatgat tatgctcagt aattttagtt cttgtgtttg 60 agttcgagtt tctttatggt tttgtgttac cgtggttctt gtttttgacc aatatatctg 120 gttgtttata gtcgatttaa tgaaatgata atcagaaatt ggagtattga agttctacac 180 atttttactt tttgtgtgct ggatgtggaa aatattctat ttcacgaatg cttgtcttgt 240 tgttattctt cttccgaaca caacaggcta agcagccttc aaaacaaaaa aaacaactaa 300 attcacaaaa cctcgacgga aattttccta cagttttgcc tgtgaaagag agagacacaa 360 ttttcacgcc caatgttctc aaaggattgg gttctcaagt gtgcagattg gtgagaaaaa 420 tagtacatcg aaatcgaaca ttttttttct gagaacatga aatgatattc atcctcaagg 480 ccgtgtatat gtttagctat gttcagacct atgaattcat gaaacatgtc acatcctctt 540 gttgatttta atttgatgaa agcttctgat atccagagga acattattaa aagtccaatt 600 gtttctacag aactaattgc aatcctacgt gacagcaagc acgatgtcat ggcttactaa 660 aatattaaga aaaaaaatca tagactcggt gcttttagac aaatagagca ttgttgattg 720 ttaagtcaat cctctctttt gggtataggg tggtctcata acatttgtag gcagggatta 780 ttctagcaat ttttcaaagt actttatatt ccgaattttg cctgattgct ttgttgttcc 840 acaaaagata caaataattg catatttgaa ttgtagtgag tatagtttac tagtaaaagt 900 atgaataatt gtatatttga attgtagtga gtatagttta gtggtaaaag tatgattctt 960 tcatggactc gactcctaaa tagttaaggt agtcaagaaa 1000 <210> 30 <211> 1000 <212> DNA <213> Artificial Sequence <220> <223> Synthetic Polynucleotide <400> 30 gctgtttcaa tactgtggta gtgctataaa ttggcctact ttttgtttct tacagtctat 60 tagcctagca gccgttaggc ctctttttta aatgtaataa gttgaattcc tgaactcgtg 120 aagcttgccc cttattgaac cgtagtgttt ttggttgctt aataccatta agcattgagt tgttttggat ttattgcat ttaccgaatt ttattgga gatagtaagc gttttttcca tgttcacaaa tatgccatga aaaaagcagt aaaatttcaa taaaccaaca tcatgataa acaaaagtat gcatcgtatg aaaaaagtg ggtgatgaaa tgataagtct aattttggtc gaatttggtc gttgttattt ttgcatgaac atctctttg tacaacctaa caactaattt gctattttta atatttttgt actgcttttg atttgcttgc tcttcacaat attatagtgt 480 tgcattagtt gttcaatttt ggttgtacaa father ttttaagcag ttatcgtgaa tgttagaaaa atcatgtgac ttatctctgt tattgggtga ttgcatttgt ttcgtgactt gtctttaatc ggttacttat tttcaatat aaataacaat atagcatat tttgtgtcac tttcttactt ttgattattg aaaagccgtg ctcctttgcc tgtctcttga gccatgtgat 720 tcgtcgtgaa ttgtgaggac gagatcatat ttgagaaaga aaatgtgagc tagacgtttc 780 father ttacgtagcc cttgcaattc aattcagcag ggaacatatc aaaatgattt gtattgaaaa aattgttcta cctacaaaaa tctactttat tatttgtact gaacgagaaa 900 gtgccacaat acttaattag ataagtagac attggagcta atctcaaaat tcttgcctgc 960 tttttctatc atatatctcc atatcactaa ttaattcatt 1000 <210> 31 <211> 2000 <212> DNA <213> Artificial sequence <220> <223> Composite <400> 31 aaaactttca catgaatagc acgaagaatc acaatgaacg attgatcttc tttaaaatc 60 aaatattaat tgggaaataa aaaaataaaa aatggaagtt cacaatatag tgttcgtgtg 120 cttttcatga aaactgtttt tgtaactttc agcatttttc atataattag gtcatgttgg 180 gtataattag ctataaaatt agttaaaaat ttaaaaatta gttggtaact taaagttaaa 240 aagtaactta ttaaattaaa aatattttaa taaaattaat tgttaaaata attgaaaagt 300 ataaataac aaaaaataat aaatcaatta atttaaataa gataactagg aaaataaata 360 aaagattaaa aaaaactaaa aaactaaaaaa actaaagttt taaataatgt ttaaaaatag 420 ttaaaatta ttaaaaactt atttaaaa cagttaaatt aacaac tttcgctta 480 tgaaaataa aagcttacct aactttagta gatacttgt ccaaatta gttgatacct 540 attgccctta agttttctt attcatt attggttttg tcacaagct atcttttaat 600 cttaatttat tgtaaaaaa tccgtcgcct tcatttaca catctgctca 660 ttagaaaaat aaaatttctc ctaaacgatt agtagaaaaa atcattttaa taatgaataa 720 gaaagaata taggaaaaa attacktcat ttaaaaaaa cattttggatt atattttact 780 ttaaaatac taaatatttt taaatgacta attttatata cactgtact aaagtatac 840 aagttattat gttatgtatc aaagaat acttaaaaa tctactgaag atatcttac 900 aaaaaaaaaaaaaaaaaaaaaaaactg tgaaattt atgaattt tgaaaattg 960 aaaaaataat tattaaagaa tttagtggag tagaaagct ttccgatt tctttttttc 1020 catataaaa aaatctagca tgacagcttt tccatagatt ttaataatgt aaatactag 1080 tagcagccga ccgttcaggt aatggaccct ataaatttc gaacgctcca ctccacttgc 1140 aacgagtgcg ggccccaatt tataacgcc gtcgtaacag ataaagtcca acgtgaagcg 1200 gtgaaggtgc atctctgact ccgtcaagat tacgaaaccg ctaattacga aggactcccc 1260 gaaaatgcat ccaataccga aatatcatgt gtgataagca ccaagtgaca ccatacatga 1320 gcacgcgtca caatatgatt ggagaacagt tccaccacat atgctataaa ttgcccccac 1380 acccctcgtc catcttcgca gttcaattc aatcaaatta gttcattctc tttgcgcagt 1440 tccctacctc tccattcaag gttcgtaaat ttttctgtt ttcttttttt cttttttcg 1500 ttattgtttg ttcttcatca gcatgatgtt gatttgattg tgttctacat agtttcatcg 1560 aatcttaatt ttcataatca gaatcagctt ttattaatgc aagaactttt ttaatggatg 1620 attttacaat cgtatattag gtctaattag agtttttttt cataaaaaat ttcagatccg 1680 tttacaaaa gccttaattt agattctgta gtcgtagatt agggtttttt ttttcattta 1740 ttacttcaga tccgttaaag aacagcctta tttgttgata cttcagtcgt ttttcaagaa 1800 attgtcagac cagttgaaaa aagcctgatt cgttgattct gtatagtttt tcaagagata 1860 ttgctcagat ctgttagcaa ctgccttatc tgttgattct atggccatag attaggggtt 1920 tttttctctc catgaaattg cttcttaaaa ctacgtgatg gattttgatt ctgatttatc 1980 tgtgattgtt gattctacag 2000

Claims

1. An expression cassette comprising the nucleotide sequence of SEQ ID NO: 1, wherein the nucleotide sequence is operably linked to a heterologous nucleotide sequence.

2. An expression cassette comprising a first nucleotide sequence of SEQ ID NO: 1 and a second nucleotide sequence of one or more of SEQ ID NOs: 8-29, wherein the first and / or second nucleotide sequence is operably linked to a heterologous nucleotide sequence.

3. The expression cassette of claim 1 or 2, wherein the heterologous nucleotide sequence is a nucleic acid of interest encoding a target RNA or protein.

4. The expression cassette of claim 3, wherein the target RNA or protein can confer antibiotic resistance, virus resistance, insect resistance, herbicide tolerance, improved nutritional value or altered reproductive ability to soybean plants.

5. The expression cassette of claim 3, wherein the target RNA or protein can confer resistance to other harmful organisms on soybean plants.

6. The expression cassette of claim 3, wherein the target RNA or protein can confer disease resistance to soybean plants.

7. The expression cassette of claim 1, wherein the heterologous nucleotide sequence encodes a selectable marker or wherein the expression cassette further comprises a selectable marker.

8. A vector comprising the expression cassette according to any one of claims 1 to 7.

9. The vector of claim 8, wherein the vector is a plasmid, a virus or an Agrobacterium.